<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7650599</article-id><article-id pub-id-type="pmid">33053825</article-id><article-id pub-id-type="doi">10.3390/ph13100303</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-13-00303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>Terminalia bentzo&#x000eb;</italic>, a Mascarene Endemic Plant, Inhibits Human Hepatocellular Carcinoma Cells Growth In Vitro via G0/G1 Phase Cell Cycle Arrest</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rummun</surname><given-names>Nawraj</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00303">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00303">2</xref><xref ref-type="aff" rid="af3-pharmaceuticals-13-00303">3</xref></contrib><contrib contrib-type="author"><name><surname>Rondeau</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="af4-pharmaceuticals-13-00303">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3731-150X</contrib-id><name><surname>Bourdon</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="af4-pharmaceuticals-13-00303">4</xref></contrib><contrib contrib-type="author"><name><surname>Pires</surname><given-names>Elisabete</given-names></name><xref ref-type="aff" rid="af5-pharmaceuticals-13-00303">5</xref></contrib><contrib contrib-type="author"><name><surname>McCullagh</surname><given-names>James</given-names></name><xref ref-type="aff" rid="af5-pharmaceuticals-13-00303">5</xref></contrib><contrib contrib-type="author"><name><surname>Claridge</surname><given-names>Timothy D. W.</given-names></name><xref ref-type="aff" rid="af5-pharmaceuticals-13-00303">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8099-9090</contrib-id><name><surname>Bahorun</surname><given-names>Theeshan</given-names></name><xref ref-type="aff" rid="af2-pharmaceuticals-13-00303">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3706-6068</contrib-id><name><surname>Li</surname><given-names>Wen-Wu</given-names></name><xref ref-type="aff" rid="af3-pharmaceuticals-13-00303">3</xref><xref rid="c1-pharmaceuticals-13-00303" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Neergheen</surname><given-names>Vidushi S.</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00303">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00303">2</xref><xref rid="c1-pharmaceuticals-13-00303" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-13-00303"><label>1</label>Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, R&#x000e9;duit 80837, Mauritius; <email>n.rajeevr10@gmail.com</email></aff><aff id="af2-pharmaceuticals-13-00303"><label>2</label>Biopharmaceutical Unit Centre for Biomedical and Biomaterials Research, MSIRI Building, University of Mauritius, R&#x000e9;duit 80837, Mauritius; <email>tbahorun@uom.ac.mu</email></aff><aff id="af3-pharmaceuticals-13-00303"><label>3</label>School of Pharmacy and Bioengineering, Faculty of Medicine and Health Sciences, Keele University, Thornburrow Drive, Stoke on Trent ST4 7QB, UK</aff><aff id="af4-pharmaceuticals-13-00303"><label>4</label>Universit&#x000e9; de La R&#x000e9;union, INSERM, UMR 1188 Diab&#x000e8;te ath&#x000e9;rothrombose Th&#x000e9;rapies R&#x000e9;union Oc&#x000e9;an Indien (D&#x000e9;TROI), Saint-Denis de La R&#x000e9;union, 97490 Sainte-Clotilde, Reunion, France; <email>rophil@univ-reunion.fr</email> (P.R.); <email>emmanuel.bourdon@univ-reunion.fr</email> (E.B.)</aff><aff id="af5-pharmaceuticals-13-00303"><label>5</label>Chemical Research Laboratory, University of Oxford, Oxford OX1 3TA, UK; <email>elisabete.pires@chem.ox.ac.uk</email> (E.P.); <email>james.mccullagh@chem.ox.ac.uk</email> (J.M.); <email>tim.claridge@chem.ox.ac.uk</email> (T.D.W.C.)</aff><author-notes><corresp id="c1-pharmaceuticals-13-00303"><label>*</label>Correspondence: <email>w.li@keele.ac.uk</email> (W.-W.L.); <email>v.neergheen@uom.ac.mu</email> (V.S.N.)</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>13</volume><issue>10</issue><elocation-id>303</elocation-id><history><date date-type="received"><day>10</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>08</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Tropical forests constitute a prolific sanctuary of unique floral diversity and potential medicinal sources, however, many of them remain unexplored. The scarcity of rigorous scientific data on the surviving Mascarene endemic taxa renders bioprospecting of this untapped resource of utmost importance. Thus, in view of valorizing the native resource, this study has as its objective to investigate the bioactivities of endemic leaf extracts. Herein, seven Mascarene endemic plants leaves were extracted and evaluated for their in vitro antioxidant properties and antiproliferative effects on a panel of cancer cell lines, using methyl thiazolyl diphenyl-tetrazolium bromide (MTT) and clonogenic cell survival assays. Flow cytometry and comet assay were used to investigate the cell cycle and DNA damaging effects, respectively. Bioassay guided-fractionation coupled with liquid chromatography mass spectrometry (MS), gas chromatography-MS, and nuclear magnetic resonance spectroscopic analysis were used to identify the bioactive compounds. Among the seven plants tested, <italic>Terminalia</italic>
<italic>bentzo&#x000eb;</italic> was comparatively the most potent antioxidant extract, with significantly (<italic>p</italic> &#x0003c; 0.05) higher cytotoxic activities. <italic>T. bentzo&#x000eb;</italic> extract further selectively suppressed the growth of human hepatocellular carcinoma cells and significantly halted the cell cycle progression in the G0/G1 phase, decreased the cells&#x02019; replicative potential and induced significant DNA damage. In total, 10 phenolic compounds, including punicalagin and ellagic acid, were identified and likely contributed to the extract&#x02019;s potent antioxidant and cytotoxic activities. These results established a promising basis for further in-depth investigations into the potential use of <italic>T. bentzo&#x000eb;</italic> as a supportive therapy in cancer management.</p></abstract><kwd-group><kwd><italic>Terminalia bentzo&#x000eb;</italic></kwd><kwd>Mascarene endemic</kwd><kwd>cancer</kwd><kwd>cytotoxicity</kwd><kwd>antioxidant</kwd><kwd>cell cycle arrest</kwd><kwd>phenolics</kwd><kwd>bioassay-guided fractionation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceuticals-13-00303"><title>1. Introduction</title><p>The plant kingdom is known to be a prolific sanctuary of phytochemicals with unique therapeutic potential. At least 25% of the 1562 clinical drugs approved by the US Food and Drugs Administration are known to have been derived from terrestrial plants [<xref rid="B1-pharmaceuticals-13-00303" ref-type="bibr">1</xref>,<xref rid="B2-pharmaceuticals-13-00303" ref-type="bibr">2</xref>]. Moreover, an estimated 28,187 plant taxa, globally, are documented to have medicinal values, with over 3000 species reported with the ethnomedicinal application against cancer [<xref rid="B3-pharmaceuticals-13-00303" ref-type="bibr">3</xref>,<xref rid="B4-pharmaceuticals-13-00303" ref-type="bibr">4</xref>]. The continued dependence of mankind on plants was further evidenced during the recent outbreak of the COVID-19 pandemic, whereby herbal medicines were used in an attempt to mitigate the symptoms of the novel coronavirus infection [<xref rid="B5-pharmaceuticals-13-00303" ref-type="bibr">5</xref>,<xref rid="B6-pharmaceuticals-13-00303" ref-type="bibr">6</xref>,<xref rid="B7-pharmaceuticals-13-00303" ref-type="bibr">7</xref>].</p><p>Madagascar and its neighboring islands in the Western Indian Ocean regions are known as biodiversity hotspots [<xref rid="B8-pharmaceuticals-13-00303" ref-type="bibr">8</xref>]. Undoubtedly, untapped endemic plant species from these niche areas broaden the structural variation of novel chemotypes [<xref rid="B9-pharmaceuticals-13-00303" ref-type="bibr">9</xref>,<xref rid="B10-pharmaceuticals-13-00303" ref-type="bibr">10</xref>]. The tropical forest of Madagascar was once acknowledged as a fertile source of economically valuable plants with pharmacologically active ingredients [<xref rid="B11-pharmaceuticals-13-00303" ref-type="bibr">11</xref>]. Indeed, the anticancer drugs vinblastine and vincristine were derived from the Madagascan endemic <italic>Catharanthus roseus</italic> (Apocynaceae) [<xref rid="B12-pharmaceuticals-13-00303" ref-type="bibr">12</xref>]. Certainly, the market value of vincristine alone was estimated to be USD 15 million per kilogram, in the year 2016 [<xref rid="B13-pharmaceuticals-13-00303" ref-type="bibr">13</xref>].</p><p>Phytogeography investigations revealed that the Mascarene endemic plants have their ancestral lineages tracing back to Madagascar [<xref rid="B14-pharmaceuticals-13-00303" ref-type="bibr">14</xref>]. As such, the unique floral biodiversity of Mauritius is expected to possess similar medicinal and therapeutic prolificacy as the Madagascan rain forest. However, instead of conserving such valuable biodiversity, human activities are pushing endemic taxa towards an unprecedented extinction crisis. In less than 400 years of human settlement, Mauritius has witnessed the shrinking of its native forest to around 5% of the original cover, leading to the permanent loss of 30 (10.9%) of its endemic plant species and driving 81.7% of the remnant endemic taxa to the brink of extinction [<xref rid="B15-pharmaceuticals-13-00303" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceuticals-13-00303" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceuticals-13-00303" ref-type="bibr">17</xref>]. For instance, fewer than 500 adults trees of <italic>Terminalia bentzo&#x000eb;</italic> (L.) L.f. subsp. <italic>bentzo&#x000eb;</italic> are recorded in the wild, defining the species survival as vulnerable, as per the International Union for Conservation of Nature red list criteria [<xref rid="B18-pharmaceuticals-13-00303" ref-type="bibr">18</xref>]. Nevertheless, the remnant areas of the pristine forest are still home to a plethora of endemic flora rich in high genetic diversity, representing interesting sources for complementary and alternative medicine, nutraceuticals, as well as pharmaceutical leads [<xref rid="B16-pharmaceuticals-13-00303" ref-type="bibr">16</xref>].</p><p>The initiation and progression of cancer involve oxidative stress via DNA damage, and the increase of DNA mutations. Conventional chemo- and radiotherapy cause cancer cell death often through the generation of reactive oxygen species (ROS), but also unfortunately lead to severe side effects. It is highly desired to develop more effective therapies with less toxic effects [<xref rid="B19-pharmaceuticals-13-00303" ref-type="bibr">19</xref>]. Plant polyphenols exert anticarcinogenic activity by interfering with the different hallmarks of cancer, including sustained tumor cell proliferation, angiogenesis and apoptotic cell death, through various signaling pathways [<xref rid="B19-pharmaceuticals-13-00303" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceuticals-13-00303" ref-type="bibr">20</xref>]. Polyphenolics can also behave as antioxidants, thereby maintaining the integrity of DNA from oxidative stress attack and preventing the initiation stage of carcinogenesis [<xref rid="B21-pharmaceuticals-13-00303" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceuticals-13-00303" ref-type="bibr">22</xref>].</p><p>The tropical island of Mauritius is known for its endemic biodiversity richness [<xref rid="B8-pharmaceuticals-13-00303" ref-type="bibr">8</xref>]. However, human activities on the island have provoked the irreversible loss of a considerable fraction of this genetic resource. For instance, in less than four centuries, Mauritius has lost 95% of its pristine forest cover, accounting for the extinction of 10.9% of the island&#x02019;s endemic flora [<xref rid="B23-pharmaceuticals-13-00303" ref-type="bibr">23</xref>]. The scarcity of rigorous scientific data on the surviving endemic taxa renders the bioprospecting of this untapped resource of utmost importance. With this in mind, and in view of providing solid foundations to enforce stringent conservation policies, the in vitro antioxidant propensities of leaf extracts from seven plants endemic to Mascarene islands were investigated, in relation to their polyphenolic content. The plants under study have documented traditional uses against ailments ranging from dermatological conditions, to asthma, to infectious diseases (<xref rid="pharmaceuticals-13-00303-t001" ref-type="table">Table 1</xref>). The cytotoxic effect of <italic>Terminalia bentzo&#x000eb;</italic>, on a panel of cancer cell lines, and its ability to impede the cell cycle progression in hepatocellular carcinoma (HepG2) cells were determined. The bioactive constituents in <italic>T. bentzo&#x000eb;</italic> leaf extract were characterized following bioassay-guided fractionation.</p></sec><sec sec-type="results" id="sec2-pharmaceuticals-13-00303"><title>2. Results</title><sec id="sec2dot1-pharmaceuticals-13-00303"><title>2.1. Estimation of Polyphenols Level in the Investigated Leaf Extracts</title><p>The phenolic content varied significantly among the seven leaf extracts under study (<italic>p</italic> &#x0003c; 0.05), with amounts ranging between 70.2 &#x000b1; 4.72 mg and 385 &#x000b1; 24.1 mg gallic acid equivalent/g. The total flavonoid levels ranged between 2.43 &#x000b1; 0.06 mg and 12.9 &#x000b1; 0.45 mg quercetin equivalent/g. Based on the spectrophotometric assay results, the estimated levels of phenolics and flavonoids were significantly the highest (<italic>p</italic> &#x0003c; 0.05) in <italic>T. bentzo&#x000eb;</italic> leaf extract as compared to the other investigated leaf extracts (<xref rid="pharmaceuticals-13-00303-t002" ref-type="table">Table 2</xref>). While the proanthocyanidin content prevailed in the <italic>E. sideroxyloides</italic> leaf, both the <italic>S. lineata</italic> leaf and <italic>T. bentzo&#x000eb;</italic> leaf had a remarkably negligible amount of proanthocyanidin detected by the butanol/HCl assay.</p></sec><sec id="sec2dot2-pharmaceuticals-13-00303"><title>2.2. In Vitro Antioxidant Activities of the Investigated Leaf Extracts</title><p>An array of five analytical models was used to benchmark the antioxidant potential of the investigated leaf extracts. The Mascarene endemic plant leaf extracts exhibited a varying degree of activities in the different antioxidant assays. All extracts showed a dose-dependent metal chelating and free radical scavenging activity (<xref rid="pharmaceuticals-13-00303-t002" ref-type="table">Table 2</xref>). In terms of iron chelation, all the extracts were weak chelators compared to EDTA, with an IC<sub>50</sub> value of 0.01 &#x000b1; 0.00 mg/mL (23.6 &#x000b1; 0.22 &#x000b5;M) (<italic>p</italic> &#x02264; 0.05). As depicted in <xref rid="pharmaceuticals-13-00303-t002" ref-type="table">Table 2</xref>, among the seven accessions of plants, <italic>T. bentzo&#x000eb;</italic> showed the most effective antioxidant potential in all the five antioxidant assays. Thus, the free radical quenching activity of <italic>T. bentzo&#x000eb;</italic> was further evaluated in a hydroxyl radical scavenging assay. <italic>T. bentzo&#x000eb;</italic> (IC<sub>50</sub> = 0.25 &#x000b1; 0.03 mg/mL) exhibited a significantly (<italic>p</italic> &#x0003c; 0.0001) greater degree of protection against Fenton-mediated oxidative damage to 2-deoxyribose sugar moiety as compared to gallic acid (IC<sub>50</sub> = 1.65 &#x000b1; 0.09 mg/mL).</p></sec><sec id="sec2dot3-pharmaceuticals-13-00303"><title>2.3. Effect of T. bentzo&#x000eb; Leaf Extract on Cell Survival</title><p>To assess the antiproliferative properties of the <italic>T. bentzo&#x000eb;</italic> leaf extract on cancer cells, first, the influence of the extracts on the cell viabilities of five cancer cell lines, notably human liposarcoma (SW872), human lung carcinoma (A549), human hepatocellular carcinoma (HepG2), and human ovarian carcinoma OVCAR-4 and OVCAR-8 cells, was investigated using the methyl thiazolyl diphenyl-tetrazolium bromide (MTT) assay. <italic>T. bentzo&#x000eb;</italic> suppressed the growth of all cancer cell lines in a dose-dependent manner. However, the dose of extract required to reach the half-maximal inhibitory concentration differed considerably among the various cancer cell types. The cytotoxicity of <italic>T. bentzo&#x000eb;</italic> was also evaluated against the non-malignant human ovarian epithelial (HOE) cells and the <italic>IC<sub>50</sub></italic> value obtained (<xref rid="pharmaceuticals-13-00303-t003" ref-type="table">Table 3</xref>). HepG2 cells were more sensitive to <italic>T. bentzo&#x000eb;</italic> treatment (selective index value 2.4 compared to HOE cells) (<xref rid="pharmaceuticals-13-00303-t003" ref-type="table">Table 3</xref>). At 48 h of exposure, the highest concentration of <italic>T. bentzo&#x000eb;</italic> extract (100 &#x000b5;g/mL) reduced HepG2 cell viability to 20% as compared to the untreated control cells (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S1A</xref>). Subsequently, the effect of <italic>T. bentzo&#x000eb;</italic> extract on the replicative ability of HepG2 cells was evaluated using the clonogenic cell survival assay. <italic>T. bentzo&#x000eb;</italic> treatment significantly (<italic>p</italic> &#x0003c; 0.0001) reduced the number of surviving HepG2 colonies as compared to untreated control cells (<xref ref-type="fig" rid="pharmaceuticals-13-00303-f001">Figure 1</xref>).</p></sec><sec id="sec2dot4-pharmaceuticals-13-00303"><title>2.4. Genotoxic Effect of T. bentzo&#x000eb; Extract in HepG2 Cells.</title><p>The DNA damage induced by the <italic>T. bentzo&#x000eb;</italic> leaf extract was assessed in HepG2 cells by the alkaline comet assay. Treatment with 10 &#x000b5;g/mL <italic>T. bentzo&#x000eb;</italic> leaf extract for 24 h resulted in the induction of significant (<italic>p</italic> &#x02264; 0.0001) DNA damage in HepG2 cells as compared to untreated control cells. The occurrence of DNA damaged was scored in terms of tail length, tail intensity and olive tail moment of cell cultures by comet assay software (<xref rid="pharmaceuticals-13-00303-t004" ref-type="table">Table 4</xref><bold>)</bold>. The increased olive tail moment in response to <italic>T. bentzo&#x000eb;</italic> treatment was four-fold higher than that of untreated control cells. Cells treated with 200 &#x000b5;M H<sub>2</sub>O<sub>2</sub> for 30 min were used as a positive control.</p></sec><sec id="sec2dot5-pharmaceuticals-13-00303"><title>2.5. T. bentzo&#x000eb; Induced Cell Death</title><p>The proportion and distribution of HepG2 cells stained by annexin V- fluorescein isothiocyanate (FITC) and propidium iodide (PI) after 48 h of exposure to <italic>T. bentzo&#x000eb;</italic> extract are illustrated in <xref ref-type="fig" rid="pharmaceuticals-13-00303-f002">Figure 2</xref>A and <xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S2</xref>. The results indicated that, at a concentration equivalent to 10 &#x000b5;g/mL and 20 &#x000b5;g/mL, the distribution pattern of the cell populations in the different quadrants (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S2</xref>) is similar to that of the dimethyl sulfoxide (DMSO) control. However, the exposure of HepG2 cells for 48 h at 40 &#x000b5;g/mL stimulated a significant increase in annexin V (1.41-fold, <italic>p</italic> &#x0003c; 0.01) and PI (1.52-fold, <italic>p</italic> &#x0003c; 0.001) fluorescence compared to the control. This increase is notably reflected in a higher percentage of necrotic cells (11.7%, <italic>p</italic> &#x0003c; 0.01) compared to the DMSO control (4.33%), indicating apoptotic/necrotic cell death at this test concentration. Etoposide significantly (<italic>p</italic> &#x0003c; 0.001) increased the proportion of cells undergoing apoptosis (between 10% and 12%)/necrosis (between 16% and 21%) at all three test doses, relative to DMSO control.</p></sec><sec id="sec2dot6-pharmaceuticals-13-00303"><title>2.6. Cell Cycle Progression and T. bentzo&#x000eb;</title><p>The flow cytometric analysis of DNA content of the HepG2 cells treated with test extracts for 48 h allowed the determination of the percentage of the cell population in each phase of the cell cycle. As emphasized in <xref ref-type="fig" rid="pharmaceuticals-13-00303-f002">Figure 2</xref>B and <xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S3</xref>, the exposure of HepG2 cells to 40 &#x000b5;g/mL of <italic>T. bentzo&#x000eb;</italic> induced G0/G1 cell cycle arrest by increasing the cell population in G0/G1 (until 73.1 &#x000b1; 1.76%, <italic>p</italic> &#x0003c; 0.01 vs. ctrl) to the detriment of the G2/M phase (until 17.92 &#x000b1; 1.76%, <italic>p</italic> &#x0003c; 0.001 vs. ctrl). In contrast, the treatment with 4 &#x000b5;g/mL etoposide led to the accumulation of G2/M cell fraction (until 53.6 &#x000b1; 5.55%), to the detriment of the G0/G1 cells fraction (42.2 &#x000b1; 6.25%), suggesting the G2/M arrest of HepG2 cell progression.</p></sec><sec id="sec2dot7-pharmaceuticals-13-00303"><title>2.7. Bioassay Guided Fractionation of T. bentzo&#x000eb; Leaf Extract</title><sec id="sec2dot7dot1-pharmaceuticals-13-00303"><title>2.7.1. Effect of <italic>T. bentzo&#x000eb;</italic> Fractions on HepG2 Cell Viability</title><p>HepG2 cells were used as a model to fractionate and characterize the bioactive components present in <italic>T. bentzo&#x000eb;</italic> leaf extract. The first round of fractionation was achieved using liquid&#x02013;liquid portioning with organic solvents of increasing polarities. The <italic>T. bentzo&#x000eb;</italic> butanol fraction, being the most active, was further fractionated on a Sephadex LH-20 column. A total of 11 subfractions was derived, with their cytotoxic activity being limited between fractions F4 to F10 only (<xref rid="pharmaceuticals-13-00303-t005" ref-type="table">Table 5</xref>). The assessment of their chromatographic patterns revealed differences in the chemical compositions of the fractions, albeit with multiple overlapping peaks highlighting the chemical complexity of the subfractions. Given the most potent cytotoxic activity of the subfraction F6 (IC<sub>50</sub> = 15.2 &#x000b1; 1.8 &#x000b5;g/mL), the further fractional separation of the latter was achieved using preparative high performance liquid chromatography (HPLC) to yield 11 HPLC subfractions (F6.1&#x02013;F6.11). Of these, HPLC subfraction F6.1 retained most of the cytotoxic activity, providing an IC<sub>50</sub> value of 15.8 &#x000b1; 0.3 &#x000b5;g/mL. By contrast, HPLC fractions F2, F7, F9, F10 and F11 failed to effectively inhibit the growth of HepG2 cell cultures; hence no IC<sub>50</sub> values were determined for these subfractions. A summary of the bioassay-guided fractionation employed is depicted in <xref ref-type="fig" rid="pharmaceuticals-13-00303-f003">Figure 3</xref>.</p></sec><sec id="sec2dot7dot2-pharmaceuticals-13-00303"><title>2.7.2. Antioxidant Potential of <italic>T. bentzo&#x000eb;</italic> Fractions</title><p>Both the ethyl acetate (22 &#x000b1; 0.29 mmol Fe<sup>2+</sup>) and butanol (21.01 &#x000b1; 0.56 mmol Fe<sup>2+</sup>) fractions were significantly (<italic>p</italic> &#x02264; 0.05) higher compared to the aqueous residual fraction. Furthermore, the FRAP value of the organic fractions was greater as compared to the total extract. The butanol fraction of <italic>T. bentzo&#x000eb;</italic> was a more effective scavenger of DPPH<sup>&#x02022;</sup> radical as opposed to the ethyl acetate and aqueous residual fractions (<xref rid="pharmaceuticals-13-00303-t005" ref-type="table">Table 5</xref>). As far as the butanol subfractions were concerned, notably F6, F7, and F8 had better antioxidant activities in the FRAP and superoxide radical scavenging assays (<xref rid="pharmaceuticals-13-00303-t005" ref-type="table">Table 5</xref>).</p></sec></sec><sec id="sec2dot8-pharmaceuticals-13-00303"><title>2.8. Characterization of the Cytotoxic Components of T. bentzo&#x000eb;</title><p>In an effort to identify the bioactive constituents in <italic>T. bentzo&#x000eb;</italic>, bioassay-guided fractionation was carried out. The liquid chromatography mass spectrometry (LC-MS) analysis, in conjunction with NMR spectroscopy, of the <italic>T. bentzo&#x000eb;</italic> butanol fraction 6 and its semi-prep HPLC sub-fractions allowed the identification of eight phenolic compounds, including &#x003b1; and &#x003b2;-punicalagin (<bold>1</bold>), isoterchebulin (<bold>2</bold>), terflavin A (<bold>3</bold>), 3,4,6-trigalloyl-&#x003b2;-D-glucopyranose (<bold>4</bold>), 2&#x0201d;-<italic>O</italic>-galloyl-orientin (<bold>5</bold>), 2&#x0201d;-<italic>O</italic>-galloyl-isoorientin (<bold>6</bold>), 2&#x0201d;-<italic>O</italic>-galloylvitexin (<bold>7</bold>), and ellagic acid (<bold>8</bold>) (<xref ref-type="fig" rid="pharmaceuticals-13-00303-f004">Figure 4</xref>, <xref rid="pharmaceuticals-13-00303-t006" ref-type="table">Table 6</xref>, <xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figures S4&#x02013;S7</xref>). The bioactive HPLC subfraction F6.1 (IC<sub>50</sub> value = 15.8 &#x000b1; 0.3 &#x000b5;g/mL) was revealed to be &#x003b1; and &#x003b2;-punicalagin (<bold>1</bold>) (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S5</xref>), while a mixture of isoterchebulin (<bold>2</bold>), terflavin A (<bold>3</bold>) and 3,4,6-trigalloyl-&#x003b2;-<sc>d</sc>-glucopyranose (<bold>4</bold>) (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S6</xref>) was identified from the active subfraction F6.6 (IC<sub>50</sub> value = 19.6 &#x000b1; 0.7 &#x000b5;g/mL). A mixture of 2&#x0201d;-<italic>O</italic>-galloyl-orientin (<bold>5</bold>) and 2&#x0201d;-<italic>O</italic>-galloyl-isoorientin (<bold>6</bold>) (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S7 and Table S1</xref>), with a ratio of 5:2 based on the <sup>1</sup>H NMR integration of single hydrogen in each compound, was identified from the non-active subfraction F6.9. 2&#x0201d;-<italic>O</italic>-galloylvitexin (<bold>7</bold>) and ellagic acid (<bold>8</bold>) were detected only by LC-MS from the butanol fraction 6 (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S4</xref>). Additionally, two simple phenolics, gallic acid and methyl gallate, were detected in both the ethyl acetate and butanol fractions, and identified by GC-MS analysis (<xref ref-type="app" rid="app1-pharmaceuticals-13-00303">Supplementary Figure S8</xref>). They were likely present in other less bioactive fractions. The levels of gallic and methyl gallate were quantified as 15.6 &#x000b1; 1.1 and 26.2 &#x000b1; 8.1 &#x000b5;g/mg total extract (<italic>n</italic> = 3) by HPLC, respectively.</p></sec></sec><sec sec-type="discussion" id="sec3-pharmaceuticals-13-00303"><title>3. Discussion</title><p>Medicinal plants are known to be the epicenter of numerous well-established ethnomedicinal systems across the globe [<xref rid="B4-pharmaceuticals-13-00303" ref-type="bibr">4</xref>]. However, more than 84% of these medicinal plants have been poorly studied in regards to their phytochemical compositions, clinical efficacy, as well as their safety and toxicological profiles [<xref rid="B4-pharmaceuticals-13-00303" ref-type="bibr">4</xref>]. Moreover, forest cover is being uprooted across the world, at an unprecedented rate, threatening the survival of at least 15,000 medicinal plant species [<xref rid="B30-pharmaceuticals-13-00303" ref-type="bibr">30</xref>]. Plant secondary metabolites have contributed enormously to the modern-day pharmaceutical industry by providing the chemical backbone for almost 25% of the 1562 clinical agents, as well as 60% of the 246 oncologic drugs, approved by the US Federal Drugs Administration between 1981 and 2014 [<xref rid="B1-pharmaceuticals-13-00303" ref-type="bibr">1</xref>,<xref rid="B2-pharmaceuticals-13-00303" ref-type="bibr">2</xref>,<xref rid="B31-pharmaceuticals-13-00303" ref-type="bibr">31</xref>]. As such it is of utmost importance to evaluate the unexplored terrestrial flora for their therapeutic potential, as the dwindling medicinal plant species continue to stand as a rich repository to probe for novel chemotypes in the drug developmental process.</p><p>The current findings highlight the richness of the different subclasses of polyphenolics, notably phenolics, flavonoids and proanthocyanidins, the distribution of which differed significantly (<italic>p</italic> &#x0003c; 0.05) among the investigated accessions (<xref rid="pharmaceuticals-13-00303-t002" ref-type="table">Table 2</xref>). The biosynthesis of flavonoids, in particular flavonols, is known to be upregulated in response to ultra-violet radiation [<xref rid="B32-pharmaceuticals-13-00303" ref-type="bibr">32</xref>]. The accumulation of flavonoids in the endemic plant leaves collected from Mauritius may be attributed to the high sunlight conditions and UV radiation, which are characteristic to tropical islands like the Mascarene [<xref rid="B33-pharmaceuticals-13-00303" ref-type="bibr">33</xref>].</p><p>Given the ubiquitous involvement of oxidative damage in carcinogenesis, antioxidant-rich secondary metabolites, notably polyphenolics, have attracted much interest in the search of novel and alternative treatment modalities for cancer [<xref rid="B34-pharmaceuticals-13-00303" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceuticals-13-00303" ref-type="bibr">35</xref>]. In this vein, in vitro antioxidant activities often correlated strongly with growth inhibitory activity against cancer cell lines [<xref rid="B36-pharmaceuticals-13-00303" ref-type="bibr">36</xref>,<xref rid="B37-pharmaceuticals-13-00303" ref-type="bibr">37</xref>]. However, it is crucial to note that both ROS and antioxidants have a &#x0201c;Janus-faced&#x0201d; effect in cancer management, as their effects differ in the early events of cancer initiation from those seen in the survival and propagation of established tumors [<xref rid="B34-pharmaceuticals-13-00303" ref-type="bibr">34</xref>,<xref rid="B38-pharmaceuticals-13-00303" ref-type="bibr">38</xref>]. On one hand, where a moderate ROS level promotes the transformation of normal cells to malignant cells, elevating the ROS level in cancer cells beyond the cell tolerance threshold may promote oxidative stress-induced cell cytotoxicity [<xref rid="B38-pharmaceuticals-13-00303" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceuticals-13-00303" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceuticals-13-00303" ref-type="bibr">40</xref>]. It should be noted that many standard chemotherapies cause cancer cell death via the generation of ROS and excessive oxidation [<xref rid="B41-pharmaceuticals-13-00303" ref-type="bibr">41</xref>]; therefore, the effect of antioxidant polyphenols in combination with these chemotherapies on cancers must be fully evaluated in vitro and in vivo before use in patients.</p><p>The antioxidant mechanisms of action of polyphenols are multifaceted, hence the panel of in vitro assay models used to gauge the antioxidant potential of the evaluated extracts [<xref rid="B42-pharmaceuticals-13-00303" ref-type="bibr">42</xref>]. <italic>T. bentzo&#x000eb;</italic>, having the highest abundance of total phenolics and flavonoids, also exhibited the most potent antioxidant activity in all six in vitro assays and was further evaluated for its cytotoxicity against cancer cell lines. However, the other six plant species might also show cytotoxicity through different mechanisms, which were not investigated in this study.</p><p>The cytotoxicity of different <italic>Terminalia</italic> species against multiple cancerous cell lines is documented. The investigation of the cytotoxic activity of methanolic leaf extracts of <italic>T. arjuna</italic> against human chronic myelogenous leukaemia cells led to the isolation of bioactive ursolic acid (triterpenoid) [<xref rid="B43-pharmaceuticals-13-00303" ref-type="bibr">43</xref>]. Leaf extracts of <italic>T. chebula</italic> suppressed the growth of human breast and lung cancer cell lines [<xref rid="B44-pharmaceuticals-13-00303" ref-type="bibr">44</xref>]. Along a similar line, the leaf extract from <italic>T. catappa</italic> significantly (<italic>p</italic> &#x0003c; 0.05) suppressed the proliferation of the human colorectal (SW480) cell line in a dose-dependent manner by downregulating the level of B-cell lymphoma 2 (BCL-2) gene expression while upregulating the levels of Caspase 9 and Caspase 3, indicative of the mitochondrial pathway of apoptosis in SW480 cells [<xref rid="B45-pharmaceuticals-13-00303" ref-type="bibr">45</xref>].</p><p>The foremost aim of oncologic agents is to precisely target cancerous cells with minimal effects on non-malignant cells. <italic>T. bentzo&#x000eb;</italic> crude extract had a selective index value of approximately 2.5, indicating that the extract had some degree of selectivity towards HepG2 cells as opposed to non-malignant human ovarian epithelial cells. Nevertheless, it is crucial to also assess the cytotoxicity of the extract against a panel of normal cells of different tissue origins, to provide greater insight regarding its toxicity window and safety profile.</p><p>In line with the United States National Cancer Institute cytotoxicity guidelines [<xref rid="B46-pharmaceuticals-13-00303" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceuticals-13-00303" ref-type="bibr">47</xref>], <italic>T. bentzo&#x000eb;</italic> crude extract with an IC<sub>50</sub> value of 22.8 &#x000b1; 1.3 &#x000b5;g/mL can be considered as a potent candidate for further investigation with regards to its anticancer potential. It is known that, following exposure to toxicants, a subpopulation of cells enters a dormant state. These dormant viable cells further retain their ability to replicate into stem-like progeny cells, which might lead to the development of drug-resistance and cancer relapse [<xref rid="B48-pharmaceuticals-13-00303" ref-type="bibr">48</xref>,<xref rid="B49-pharmaceuticals-13-00303" ref-type="bibr">49</xref>]. Thus, while investigating the potential anticancer effect of extracts, it is warranted to also evaluate their long-term effect on the replicative ability of the cancer cell line. The colony formation assay is a simple and useful in vitro model, considered as the gold standard to predict the long-term sensitivity of cancer cell response to therapeutics treatment [<xref rid="B48-pharmaceuticals-13-00303" ref-type="bibr">48</xref>,<xref rid="B50-pharmaceuticals-13-00303" ref-type="bibr">50</xref>]. In this vein, the current study evidenced the ability of <italic>T. bentzo&#x000eb;</italic> to impede the replicative potential of HepG2 cells (<xref ref-type="fig" rid="pharmaceuticals-13-00303-f001">Figure 1</xref>). Numerous anticancer agents, including polyphenols, are known to abrogate the limitless replicative ability of different cancer cell variants [<xref rid="B51-pharmaceuticals-13-00303" ref-type="bibr">51</xref>,<xref rid="B52-pharmaceuticals-13-00303" ref-type="bibr">52</xref>]. Catechin, catechin-3-<italic>O</italic>-gallate, 7-<italic>O</italic>-galloyl catechin and methyl gallate purified from <italic>Acasis hydaspica</italic> are reported to suppress the long-term clonal proliferation of prostate cancer (PC-3) cells [<xref rid="B53-pharmaceuticals-13-00303" ref-type="bibr">53</xref>].</p><p>This study also attempted to delineate the mode of <italic>T. bentzo&#x000eb;</italic>-induced HepG2 cell death. The flow cytometric analysis of annexin V-FITC and PI dual stained HepG2 cells treated with 40 &#x000b5;g/mL revealed a significant (<italic>p</italic> &#x0003c; 0.05) increase in both Annexin V-FITC and PI fluorescence levels, compared to the untreated control, thus indicating the putative activation of both apoptotic and necrotic pathways in HepG2 cells. Cells grown as monoculture are known to initiate apoptosis, which is terminated by necrosis-like events, also termed as secondary necrosis, due to the absence of phagocytic scavenger cells [<xref rid="B54-pharmaceuticals-13-00303" ref-type="bibr">54</xref>,<xref rid="B55-pharmaceuticals-13-00303" ref-type="bibr">55</xref>]. Numerous studies evidenced this type of cancer cell death following treatment with cytotoxic agents. Ellagic acid was reported to induce both apoptotic and necrotic cell death mechanisms in human pancreatic cancer cell cultures [<xref rid="B56-pharmaceuticals-13-00303" ref-type="bibr">56</xref>]. A similar effect of <italic>Lepidium sativum</italic> and <italic>Vitis vinifera</italic> extract was highlighted in human breast and skin cancer cells, respectively [<xref rid="B57-pharmaceuticals-13-00303" ref-type="bibr">57</xref>,<xref rid="B58-pharmaceuticals-13-00303" ref-type="bibr">58</xref>].</p><p>Plant extracts and/or the thereby-derived phytochemicals are known to provoke cancer cell death by causing oxidative damage to genetic material-mediated cell cycle arrest and subsequent cell death [<xref rid="B59-pharmaceuticals-13-00303" ref-type="bibr">59</xref>,<xref rid="B60-pharmaceuticals-13-00303" ref-type="bibr">60</xref>]. With this in mind, the DNA damage to HepG2 cellular DNA following <italic>T. bentzo&#x000eb;</italic> crude extract treatment was investigated using the alkaline comet assay, and scored in terms of tail length, tail intensity and olive tail moment. The comet assay is a well-established and highly sensitive method for the detection of DNA damage and fragmentation pattern [<xref rid="B61-pharmaceuticals-13-00303" ref-type="bibr">61</xref>]. <italic>T. bentzo&#x000eb;</italic> induced 4-fold significantly (<italic>p</italic> &#x0003c; 0.001) higher DNA damaged to HepG2 cells compared to the untreated control, as reflected by the olive tail moments (<xref rid="pharmaceuticals-13-00303-t004" ref-type="table">Table 4</xref>). Consistent with the DNA damaging ability, <italic>T. bentzo&#x000eb;</italic> halted the cell cycle progression significantly (<italic>p</italic> &#x0003c; 0.01, versus control) in the G0/G1 phase (<xref ref-type="fig" rid="pharmaceuticals-13-00303-f002">Figure 2</xref>). A similar observation was reported in lung cancer cells, where casuarinin, a tannin purified from <italic>T. arjuna</italic> L. bark, provoked the apoptotic mechanism via DNA fragmentation and G0/G1 phase cell cycle arrest [<xref rid="B62-pharmaceuticals-13-00303" ref-type="bibr">62</xref>].</p><p>It is noteworthy that the cytotoxicity of the extract may arise from the complex interplay of the cocktails of secondary metabolites present, which may act either synergistically or antagonistically to produce the overall results. Furthermore, crude extracts often comprised a pool of inactive phytoconstituents that dilute the efficacy of the active components [<xref rid="B63-pharmaceuticals-13-00303" ref-type="bibr">63</xref>,<xref rid="B64-pharmaceuticals-13-00303" ref-type="bibr">64</xref>]. It is therefore of paramount importance to purify and identify the principal bioactive components to conduct further mechanistic studies to establish their molecular mode of action [<xref rid="B63-pharmaceuticals-13-00303" ref-type="bibr">63</xref>,<xref rid="B65-pharmaceuticals-13-00303" ref-type="bibr">65</xref>]. Moreover, isolating the lead compounds also allows for potential structural modification in an attempt to enhance their selectivity and potency [<xref rid="B66-pharmaceuticals-13-00303" ref-type="bibr">66</xref>]. As such, the MTT-guided fractionation revealed that only 6 out of the 11 preparative HPLC subfractions retained the potent cytotoxicity of the crude extract (<xref ref-type="fig" rid="pharmaceuticals-13-00303-f003">Figure 3</xref>). The HPLC subfraction F6.1 was 1.4-fold more potent as compared to the crude extract.</p><p>LC-MS analysis in conjunction with NMR spectroscopy allowed the identification of eight phenolic compounds from the most bioactive subfraction F6. Punicalagin, isoterchebulin and ellagic acid have been previously reported from the bark extract of the same species collected in R&#x000e9;union Island [<xref rid="B24-pharmaceuticals-13-00303" ref-type="bibr">24</xref>]. Although the other identified compounds are being reported for the first time, to the best of our current knowledge, in <italic>T. bentzo&#x000eb;</italic> leaf, some were reported in the leaf extracts of other <italic>Terminalia</italic> species. For instance, 2&#x0201d;-<italic>O</italic>-galloylvitexin and gallic acid were identified from <italic>T. brachystemma</italic> Welw. ex Hiern and <italic>T. mollis</italic> M. Laws leaves, respectively [<xref rid="B26-pharmaceuticals-13-00303" ref-type="bibr">26</xref>]. Likewise, terflavin A was found in the <italic>T. catappa</italic> L. leaf [<xref rid="B28-pharmaceuticals-13-00303" ref-type="bibr">28</xref>].</p><p>Punicalagin and ellagic acid were reported to induce S Phase arrest and G0/G1 phase arrest in HepG2 cells, respectively [<xref rid="B67-pharmaceuticals-13-00303" ref-type="bibr">67</xref>]. Moreover, punicalagin induced G0/G1 phase arrest in papillary human thyroid carcinoma (BCPAP) cells via the NF-&#x003ba;B signaling pathway [<xref rid="B68-pharmaceuticals-13-00303" ref-type="bibr">68</xref>]. In human ovarian cancer (A2780) cells, punicalagin treatment was associated with an increase in the number of cells arrested at the G1/S phase, as well as the downregulation of the &#x003b2;-catenin signaling pathway [<xref rid="B69-pharmaceuticals-13-00303" ref-type="bibr">69</xref>]. Ellagic acid administration in prostate cancer patients was associated with decreased prostate-specific antigen, as well as reduced chemotherapy-induced myelotoxicity [<xref rid="B70-pharmaceuticals-13-00303" ref-type="bibr">70</xref>]. It may be confidently proposed that the overall cytotoxicity of <italic>T. bentzo&#x000eb;</italic> leaf extract may be a synergistic effect of the identified compounds. Gallic acid was reported to induce S phase arrest in HepG2 cells [<xref rid="B71-pharmaceuticals-13-00303" ref-type="bibr">71</xref>] and be cytotoxic to ovarian cancer cells [<xref rid="B72-pharmaceuticals-13-00303" ref-type="bibr">72</xref>]. Furthermore, gallic acid was also shown to impair centrosomal clustering in human cervical cancer (Hela) cells, thus causing a mitotic catastrophe and ultimate cell G2/M phase cell cycle arrest.</p></sec><sec id="sec4-pharmaceuticals-13-00303"><title>4. Materials and Methods</title><sec id="sec4dot1-pharmaceuticals-13-00303"><title>4.1. Plant Material and Preparation of Total Extracts</title><p>The healthy fresh leaves of seven Mascarene endemic plants were collected in Mauritius and deposited at the Mauritius herbarium, where plant species were authenticated by Kersley Pynee, National Parks &#x00026; Conservation Service, Mauritius (<xref rid="pharmaceuticals-13-00303-t001" ref-type="table">Table 1</xref>). The leaves were air-dried followed by exhaustive maceration with aqueous methanol (80%, <italic>v/v</italic>) and freeze-dried as described previously [<xref rid="B73-pharmaceuticals-13-00303" ref-type="bibr">73</xref>]. The assay results were expressed in terms of the lyophilized weight of extracts.</p></sec><sec id="sec4dot2-pharmaceuticals-13-00303"><title>4.2. Estimation of Polyphenolic Contents</title><p>The total phenolic, flavonoid, and proanthocyanidin level in the crude extracts were estimated using the Folin&#x02013;Ciocalteu assay, aluminium chloride assay and HCl/Butan-1-ol assay as described [<xref rid="B73-pharmaceuticals-13-00303" ref-type="bibr">73</xref>].</p></sec><sec id="sec4dot3-pharmaceuticals-13-00303"><title>4.3. In Vitro Antioxidant Capacities of Extracts</title><p>The antioxidant potential of the extracts was investigated according to reported methods [<xref rid="B73-pharmaceuticals-13-00303" ref-type="bibr">73</xref>,<xref rid="B74-pharmaceuticals-13-00303" ref-type="bibr">74</xref>]. Extract vehicle and gallic acid (or otherwise stated) were used as negative and positive controls, respectively. The percentage activity of the extracts was calculated relative to the negative control. GraphPad Prism 6.01 software (GraphPad, Inc., San Diego, CA, USA) was used to plot the dose&#x02013;response curves and to generate the half-maximal inhibitory concentration (IC<sub>50</sub>) values. All experiments were performed in triplicates in three independent assays. The results were expressed as mean &#x000b1; SEM.</p><sec id="sec4dot3dot1-pharmaceuticals-13-00303"><title>4.3.1. Ferric Reducing Antioxidant Potential (FRAP) Assay</title><p>The final reaction volume of 3.4 mL of the ferric reducing antioxidant power assay contained 100 &#x000b5;L of extract and 300 &#x000b5;L of water followed by the addition of 3 mL FRAP reagent. The FRAP reagent was prepared immediately before use by mixing 100 mL of 0.25 M acetate buffer (pH 3.6), 10 mL of 20 mM ferric chloride (source of Fe<sup>3+</sup>) and 10 mL of 10 mM 2,4,6-tripyridyl-s-triazine. After incubating the mixture for 4 min at ambient temperature, the absorbance was read at 593 nm against a blank. Results were reported as in mmol Fe<sup>2+</sup>.</p></sec><sec id="sec4dot3dot2-pharmaceuticals-13-00303"><title>4.3.2. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Assay</title><p>The DPPH assay protocol involved mixing varying concentrations, between 0 and 25 &#x000b5;g/mL, of 100 &#x000b5;L of the methanolic extract with 200 &#x000b5;L of 100 &#x000b5;M methanolic DPPH and absorbances were read at 492 nm, 30 min post-incubation at ambient temperature.</p></sec><sec id="sec4dot3dot3-pharmaceuticals-13-00303"><title>4.3.3. Iron Chelating Assay</title><p>The reaction mixture for the iron chelating activity contained 40 &#x000b5;L of plant extract (concentrations between 0 and 10 mg/mL), 10 &#x000b5;L of FeCl<sub>2</sub>&#x022c5;4H<sub>2</sub>O (0.5 mM) and 150 &#x000b5;L of distilled deionized water. The mixture was incubated at ambient temperature for 5 min, before the addition of 10 &#x000b5;L of ferrozine (2.5 mM) and the absorbance was read at 562 nm.</p></sec><sec id="sec4dot3dot4-pharmaceuticals-13-00303"><title>4.3.4. Superoxide Scavenging Assay</title><p>The final 250 &#x000b5;L reaction volume for the superoxide anion scavenging assay contained 25 &#x000b5;L of plant extract (concentrations between 0 and 300 &#x000b5;g/mL), 100 &#x000b5;L of 156 &#x000b5;M of nitroblue tetrazolium, 100 &#x000b5;L of 200 &#x000b5;M beta-nicotinamide adenine dinucleotide reduced disodium salt hydrate and 30 &#x000b5;L of phenazine methosulphate. The absorbance was read at 560 nm following 30 min incubation at 25 &#x000b0;C.</p></sec><sec id="sec4dot3dot5-pharmaceuticals-13-00303"><title>4.3.5. Nitric Oxide Scavenging Assay</title><p>The nitric oxide radical scavenging activity was conducted in a 96-well plate. In total, 50 &#x000b5;L of aqueous extract (0 to 100 &#x000b5;g/mL) and 100 &#x000b5;L of 5 mM of sodium nitroprusside (in phosphate saline buffer, pH 7.4) was incubated at 25 &#x000b0;C for 150 min. After incubation, 125 &#x000b5;L of the reaction mixture was transferred to another 96-well plate, to which 100 &#x000b5;L of 0.33% sulfanilic acid in 20% glacial acetic acid was added. After 5 min, 100 &#x000b5;L of 0.1% of <italic>N</italic>-1-napthyethylenediamine dihydrochloride was added and the pink coloration formed was read at 546 nm.</p></sec><sec id="sec4dot3dot6-pharmaceuticals-13-00303"><title>4.3.6. Deoxyribose Degradation Inhibitory Assay</title><p>The deoxyribose degradation inhibitory assay protocol was optimized to a 24-well microtiter plate format. Each well contained 50 &#x000b5;L of aqueous extract, 50 &#x000b5;L of 1 mM EDTA, 100 &#x000b5;L of 500 &#x000b5;M FeCl<sub>3</sub>, 50 &#x000b5;L of 1 mM ascorbic acid, 50 &#x000b5;L of 10 mM hydrogen peroxide, 100 &#x000b5;L of 100 mM KH<sub>2</sub>PO<sub>4</sub>-KOH buffer (pH 7.4) and 100 &#x000b5;L of 15 mM 2-deoxyribose. The reaction mixture was incubated at 37 &#x000b0;C for 90 min. At the end of the incubation period, 500 &#x000b5;L of 10% (<italic>w/v</italic>) trichloroacetic acid followed by 500 &#x000b5;L of 1% (<italic>w/v</italic>) thiobarbituric acid were added to each well and the solutions were heated in a water bath at 80 &#x000b0;C for 20 min to develop the pink chromogen. The absorbance of the reaction mixture was read at 532 nm, both before and after incubation. Results were given in mg lyophilized extract/mL.</p></sec></sec><sec id="sec4dot4-pharmaceuticals-13-00303"><title>4.4. Human Cell Lines and Culture Conditions</title><p>Human liposarcoma cells (SW872), human lung carcinoma cells (A549), human hepatocellular carcinoma cells (HepG2), and human ovarian carcinoma cell lines OVCAR-4 and OVCAR-8 were purchased from American Type Culture Collection (USA). Human ovarian epithelial (HOE) cells immortalized using SV40 large T antigen were obtained from Applied Biological Materials Inc (Richmond, BC, Canada). All cell lines, except the ovarian cell lines, were cultured in Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium. Roswell Park Memorial Institute (RPMI) 1640 medium was used in the case of ovarian cell lines. Culture medium was supplemented with 10% fetal bovine serum, 2 mM L-glutamine and 100 U/L streptomycin-penicillin. Cells were grown in a humidified atmosphere of 5% carbon dioxide and 95% humidity at 37 &#x000b0;C.</p></sec><sec id="sec4dot5-pharmaceuticals-13-00303"><title>4.5. Cell-Based Assays</title><sec id="sec4dot5dot1-pharmaceuticals-13-00303"><title>4.5.1. MTT Viability Assay</title><p>The viability of the investigated cells treated with test samples was evaluated using the MTT cell viability assay as previously described [<xref rid="B75-pharmaceuticals-13-00303" ref-type="bibr">75</xref>]. Following the overnight acclimatization of cells in 96-well plate, cells were treated with test samples for 48 h and assayed for different parameters. For the 96-well plate, the seeding densities for cancer cell lines and HOE cells were 5 &#x000d7; 10<sup>3</sup> cells and 2 &#x000d7; 10<sup>3</sup> cells per well, respectively. All experiments were performed in triplicates (unless otherwise specified) in three independent assays. To compare the chemotherapeutic potential of the active extracts, the cytotoxicity of the extracts/purified compounds was evaluated against etoposide, a clinically used oncologic agent. The percentage cell viability relative to DMSO control (0.025% <italic>v/v</italic>, final concentration) was calculated and the IC<sub>50</sub> value determined using GraphPad Prism 6.01 software (GraphPad, Inc., San Diego, CA, USA).</p></sec><sec id="sec4dot5dot2-pharmaceuticals-13-00303"><title>4.5.2. Clonogenic Cell Survival Assay</title><p>The effect of the <italic>T. bentzo&#x000eb;</italic> leaf extract on the cell reproductive death was assessed by clonogenic cell survival assay according to reported methods, with slight modifications [<xref rid="B76-pharmaceuticals-13-00303" ref-type="bibr">76</xref>,<xref rid="B77-pharmaceuticals-13-00303" ref-type="bibr">77</xref>]. HepG2 cells were seeded in a 6-well plate (500/well) and allowed to attach overnight. Following a 48-h treatment period with plant extract/control, the media was replaced with fresh complete culture media and cells were grown under standard recommended culture conditions for an additional 7 days to allow large colonies&#x02019; formation. Colonies were then fixed with 4% paraformaldehyde for 30 min and stained with 0.5% (<italic>w/v</italic>) crystal violet. The individual wells were imaged using a digital camera and the colonies counted using ImageJ software, version 1.51 (the US, National Institute of Health). The cytotoxic effect was expressed as the percentage of surviving colonies relative to the untreated control.</p></sec><sec id="sec4dot5dot3-pharmaceuticals-13-00303"><title>4.5.3. Single Cell Gel Electrophoresis</title><p>Comet assay was carried out according to the method described [<xref rid="B78-pharmaceuticals-13-00303" ref-type="bibr">78</xref>,<xref rid="B79-pharmaceuticals-13-00303" ref-type="bibr">79</xref>] with minor modifications. Briefly, 30 &#x000b5;L of pre-treated cells were mixed with 70 &#x000b5;L of 1% (<italic>w/v</italic>) low melting agarose (LMA) and 40 &#x000b5;L of the cell&#x02013;LMA mixture was placed on frosted microscope slides pre-coated with 1.5% normal melting agarose. A coverslip was placed on top of the cell&#x02013;LMA mix and allowed to solidify at 4 &#x000b0;C for 1 h in the dark. Following solidification, the coverslip was gently slid off and the slides were immersed in pre-chilled lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris base, 1% <italic>v/v</italic> Triton X-100 (added 30 min before use), pH 10, 4 &#x000b0;C) for 1 h in the dark. Following this period, the excess lysis solution was drained and the slides were submerged in electrophoresis buffer (0.2 M NaOH, 1 mM EDTA, pH 13, 4 &#x000b0;C) for 30 min in the dark, to allow the DNA to unwind.</p><p>Electrophoresis was conducted for 30 min at 30 volts and 350 mA. The gels were neutralized by immersing in pre-chilled neutralization buffer (0.4 Tris-HCL, pH&#x02009;7.5, 4 &#x000b0;C) for 10 min in the dark. The slides were washed in distilled water, fixed with 4 % formalin solution for 20 min and allowed to air-dry overnight. The slides were stained with Hoechst 33342 (1 &#x000b5;g/mL), air-dried in the dark and visualized at 200&#x000d7; magnification in DAPI light cube (Ex: 357/44 nm; Em: 447/60 nm), using an EVOS fluorescence microscope (Life Technologies). Damaged DNA was measured for 100 randomly selected cells (for each independent experiment) using the Comet Assay IV 4.3.1 (Perceptive instrument, Suffolk, UK).</p></sec><sec id="sec4dot5dot4-pharmaceuticals-13-00303"><title>4.5.4. Flow Cytometric Analysis</title><p>Apoptosis/necrosis analysis was performed on HepG2 cells after 48 hours&#x02019; treatment by flow cytometry (Beckman Coulter&#x02019;s CytoFLEX and Cytexpert software, version 2.4) using Annexin V-FITC and propidium iodide (PI) double staining as described in a previous study [<xref rid="B80-pharmaceuticals-13-00303" ref-type="bibr">80</xref>]. Cell cycle analysis was performed using propidium iodide for DNA staining as described [<xref rid="B81-pharmaceuticals-13-00303" ref-type="bibr">81</xref>]. The percentages of cells in different phases (G0/G1, S and G2M phases) were quantified from propidium iodide fluorescence intensity-area (PI-A) histograms corresponding to the DNA content of HepG2 cells.</p></sec><sec id="sec4dot5dot5-pharmaceuticals-13-00303"><title>4.5.5. MTT-Guided Fractionation and Identification of Bioactive Molecules</title><p>The total extract of <italic>T. bentzo&#x000eb;</italic> was solubilized in distilled water and sequentially partitioned with ethyl acetate, followed by n-butanol. Each fraction was dried and its cytotoxicity evaluated against SW872, A549 and HepG2 using the MTT cell viability assay. The butanol fraction selective towards HepG2 cells was subjected to Sephadex LH-20 column chromatography (30 &#x000d7; 2.1 cm internal diameter) and eluted with water, water/methanol (3:1 <italic>v</italic>/<italic>v</italic>, 1:1 <italic>v</italic>/<italic>v</italic> and 1:3 <italic>v</italic>/<italic>v</italic>, respectively), methanol and acetone. The flow rate was maintained at 1.5 mL/min. Guided by the cytotoxicity against HepG2 cells and purity profile, potent sub-fractions were further fractionated using a semi-preparative HPLC column. The crude extract and thereof-derived purified sub-fractions were analyzed by extensive spectroscopic methods including GC-MS, LC-MS, HPLC, <sup>1</sup>H-NMR and <sup>13</sup>C-NMR (Supporting Information). For analytical HPLC, the concentration of standards in the crude extract was determined from the linear regression of the analytical standard curves, namely <italic>y</italic> = 12.317 <italic>x</italic>, <italic>R</italic><sup>2</sup> = 0.9996: gallic acid; and <italic>y</italic> = 16.066 <italic>x</italic>, <italic>R</italic><sup>2</sup> = 0.9992: methyl gallate.</p></sec></sec><sec id="sec4dot6-pharmaceuticals-13-00303"><title>4.6. Statistical Analysis</title><p>Statistical analyses were performed using GraphPad Prism 6.01 software (GraphPad Inc., San Diego, CA, USA). The mean values among extracts were compared using One-Way ANOVA. Student <italic>t</italic>-test and/or Tukey&#x02019;s multiple comparisons as Post Hoc test were used to determine significances in mean phytochemicals, antioxidants and cytotoxic activities among different species. All charts were generated using GraphPad Prism 6.01 software (GraphPad Inc., San Diego, CA, USA).</p></sec></sec><sec sec-type="conclusions" id="sec5-pharmaceuticals-13-00303"><title>5. Conclusions</title><p>The findings evidenced the selective long-term cytotoxicity of the antioxidant-rich <italic>T. bentzo&#x000eb;</italic> leaf extract against HepG2 cells. This plant, which is also used traditionally in the mitigation of asthma, hemorrhages, diarrhea, and sexually transmissible diseases, amongst others, has also shown some in vitro anticancer activities against HepG2 cells. The cytotoxic nature of <italic>T. bentzo&#x000eb;</italic> leaf extract against cancerous cells indicated that the <italic>T. bentzo&#x000eb;</italic> leaf has the potential to be repurposed in the mitigation of cancer as part of traditional medicine. The results so far generated support the hypothesis that <italic>T. bentzo&#x000eb;</italic> extract induces apoptosis/necrosis cell death in HepG2 cells via the degradation of cellular genetic material and the subsequent arrest of the cell cycle&#x02019;s progression in the G0/G1 phase. Overall, the MTT-guided fractionation of the crude extract and spectroscopic analyses allowed the characterization of 10 phenolic compounds, including punicalagin, ellagic acid, gallic acid and methyl gallate, that are known to have established <italic>in vitro</italic> and <italic>in vivo</italic> anticancer properties. However, the contribution of the other non-identified phytoconstituents cannot be excluded, and thus further evaluation of the identified components is warranted alongside the crude extract. The metabolite profiling of the leaf extract may be envizaged in future studies. Taking into consideration the guidelines of the US national cancer institute as well as the selectivity index observed in this study, <italic>T. bentzo&#x000eb;</italic> leaf extract has been revealed as a promising candidate that can be exploited in the search for novel anticancer agents. The current study provided base line data for more in-depth investigations of the chemotherapeutic potential of <italic>T. bentzo&#x000eb;</italic> plant extracts. Further mechanistic investigation, directed towards delineating the molecular mechanisms via which the purified bioactive entities target the aberrant signaling pathways involved in carcinogenesis, is needed to fuel <italic>in vivo</italic> studies. Future animal studies and ideally human clinical trials are warranted to establish the physiological doses for human administration.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the director and staff of Alteo Group, M&#x000e9;dine Sugar Estate and Mauritius National Park Conservation Services under the Ministry of Agro-Industry &#x00026; Food Security, Mauritius, for permission to collect endemic plant samples and the Mauritius Herbarium for plant identification.</p></ack><app-group><app id="app1-pharmaceuticals-13-00303"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/1424-8247/13/10/303/s1">https://www.mdpi.com/1424-8247/13/10/303/s1</uri>, Figure S1: Cell viability profile of HepG2 cells treated with <italic>T. bentzo&#x000eb;</italic> extract and fractions. Figure S2: Representatives annexin V-FITC/PI flow cytometric profile of HepG2 cells, 48 h post-extract/control treatment. Figure S3: Representatives cell cycle histogram of HepG2 cells, 48 h post-extract/control treatment. Figure S4: UPLC ESI MS of the butanol fraction 6 at the positive (A) and negative (B) mode. Figure S5: <sup>1</sup>H NMR spectrum (A) and HSQC spectrum (B) for punicalagin (1) in an HPLC fraction at RT 2-3 min in methanol-d<sub>4</sub>. Figure S6: <sup>1</sup>H NMR spectra for a mixture of isoterchebulin (2), terflavin A (3), and 3,4,6-trigalloyl-beta-D-glucopyranose (4) in a HPLC fraction at RT 18-20 min in acetone-d<sub>6</sub> (A) and methanol-d<sub>4</sub> (B). Figure S7: <sup>1</sup>H NMR spectra for a mixture of 2&#x0201d;-<italic>O</italic>-galloyl-orientin (3) and 2&#x0201d;-<italic>O</italic>-galloyl-isoorientin (6) with a ratio of 5:2 based on the integration of single hydrogen in each compound. Figure S8: GC-MS chromatogram of TMSi derivatives of ethyl acetate (A) and butanol (B) fraction of <italic>T. bentzo&#x000eb;</italic>. Table S1 <sup>1</sup>H NMR spectral data (500 MHz, CD<sub>3</sub>OD) of the <italic>O</italic>-galloyl-C-glycosylflavones 7 and 8 (5:2).</p><supplementary-material content-type="local-data" id="pharmaceuticals-13-00303-s001"><media xlink:href="pharmaceuticals-13-00303-s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, N.R. and V.S.N.; methodology, N.R., P.R., E.P., J.M., and T.D.W.C.; software, N.R., P.R., E.P., J.M., and T.D.W.C.; validation, N.R., P.R., E.P., J.M., and T.D.W.C.; formal analysis, N.R., P.R., W.-W.L., E.P., J.M., and T.D.W.C.; investigation, N.R., P.R., W.-W.L., E.P., J.M., and T.D.W.C.; resources, E.B., T.B., W.-W.L., and V.S.N.; data curation, N.R., P.R., E.P., J.M., and T.D.W.C.; writing&#x02014;original draft preparation, N.R.; writing&#x02014;review and editing, P.R., T.D.W.C., T.B., W.-W.L., E.B., and V.S.N.; visualization, N.R., E.P., J.M., and T.D.W.C.; supervision, T.B., W.-W.L., and V.S.N.; project administration, T.B., V.S.N.; funding acquisition, T.B., W.-W.L., and V.S.N. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by the Royal Society and Royal Society of Chemistry international exchange award (grant number: IE160622), Mauritius Research Innovation Council under the National Research and Innovation Chair Program studentship. The APC was supported by the School of Pharmacy and Bioengineering, Keele University, UK.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-13-00303"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural Products as Sources of New Drugs from 1981 to 2014</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><?supplied-pmid 26852623?><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="B2-pharmaceuticals-13-00303"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomford</surname><given-names>N.</given-names></name><name><surname>Senthebane</surname><given-names>D.</given-names></name><name><surname>Rowe</surname><given-names>A.</given-names></name><name><surname>Munro</surname><given-names>D.</given-names></name><name><surname>Seele</surname><given-names>P.</given-names></name><name><surname>Maroyi</surname><given-names>A.</given-names></name><name><surname>Dzobo</surname><given-names>K.</given-names></name></person-group><article-title>Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>1578</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19061578</pub-id><?supplied-pmid 29799486?><pub-id pub-id-type="pmid">29799486</pub-id></element-citation></ref><ref id="B3-pharmaceuticals-13-00303"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>J.G.</given-names></name><name><surname>Quinn</surname><given-names>M.L.</given-names></name><name><surname>Fabricant</surname><given-names>D.S.</given-names></name><name><surname>Farnsworth</surname><given-names>N.R.</given-names></name></person-group><article-title>Plants used against cancer&#x02014;An extension of the work of Jonathan Hartwell</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>73</volume><fpage>347</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00341-X</pub-id><pub-id pub-id-type="pmid">11090989</pub-id></element-citation></ref><ref id="B4-pharmaceuticals-13-00303"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>K.J.</given-names></name></person-group><source>State of the World&#x02019;s Plants 2017</source><comment>Report</comment><publisher-name>Royal Botanic Gardens, Kew.</publisher-name><publisher-loc>Richmond, UK</publisher-loc><year>2017</year></element-citation></ref><ref id="B5-pharmaceuticals-13-00303"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>H.W.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name></person-group><article-title>Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>1583</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9051583</pub-id><?supplied-pmid 32456123?><pub-id pub-id-type="pmid">32456123</pub-id></element-citation></ref><ref id="B6-pharmaceuticals-13-00303"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>H.W.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name></person-group><article-title>Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines</article-title><source>Integr. Med. Res.</source><year>2020</year><volume>9</volume><fpage>100465</fpage><pub-id pub-id-type="doi">10.1016/j.imr.2020.100465</pub-id><?supplied-pmid 32691000?><pub-id pub-id-type="pmid">32691000</pub-id></element-citation></ref><ref id="B7-pharmaceuticals-13-00303"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panyod</surname><given-names>S.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Sheen</surname><given-names>L.-Y.</given-names></name></person-group><article-title>Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective</article-title><source>J. Tradit. Complement. Med.</source><year>2020</year><volume>10</volume><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2020.05.004</pub-id><pub-id pub-id-type="pmid">32691006</pub-id></element-citation></ref><ref id="B8-pharmaceuticals-13-00303"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>N.</given-names></name><name><surname>Mittermeier</surname><given-names>R.A.</given-names></name><name><surname>Mittermeier</surname><given-names>C.G.</given-names></name><name><surname>da Fonseca</surname><given-names>G.A.B.</given-names></name><name><surname>Kent</surname><given-names>J.</given-names></name></person-group><article-title>Biodiversity hotspots for conservation priorities</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>853</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/35002501</pub-id><pub-id pub-id-type="pmid">10706275</pub-id></element-citation></ref><ref id="B9-pharmaceuticals-13-00303"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinghorn</surname><given-names>A.D.</given-names></name><name><surname>Farnsworth</surname><given-names>N.R.</given-names></name><name><surname>Soejarto</surname><given-names>D.D.</given-names></name><name><surname>Cordell</surname><given-names>G.A.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name><name><surname>Udeani</surname><given-names>G.O.</given-names></name><name><surname>Wani</surname><given-names>M.C.</given-names></name><name><surname>Wall</surname><given-names>M.E.</given-names></name><name><surname>Navarro</surname><given-names>H.A.</given-names></name><name><surname>Kramer</surname><given-names>R.A.</given-names></name><etal/></person-group><article-title>Novel Strategies for the Discovery of Plant-Derived Anticancer Agents</article-title><source>Pure Appl. Chem.</source><year>1999</year><volume>71</volume><fpage>1611</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1351/pac199971091611</pub-id></element-citation></ref><ref id="B10-pharmaceuticals-13-00303"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinghorn</surname><given-names>A.D.</given-names></name><name><surname>De Blanco</surname><given-names>E.J.C.</given-names></name><name><surname>Lucas</surname><given-names>D.M.</given-names></name><name><surname>Rakotondraibe</surname><given-names>H.L.</given-names></name><name><surname>Orjala</surname><given-names>J.</given-names></name><name><surname>Soejarto</surname><given-names>D.D.</given-names></name><name><surname>Oberlies</surname><given-names>N.H.</given-names></name><name><surname>Pearce</surname><given-names>C.J.</given-names></name><name><surname>Wani</surname><given-names>M.C.</given-names></name><name><surname>Stockwell</surname><given-names>B.R.</given-names></name><etal/></person-group><article-title>Discovery of Anticancer Agents of Diverse Natural Origin</article-title><source>Anticancer Res.</source><year>2016</year><volume>36</volume><fpage>5623</fpage><lpage>5638</lpage><pub-id pub-id-type="doi">10.21873/anticanres.11146</pub-id><pub-id pub-id-type="pmid">27793884</pub-id></element-citation></ref><ref id="B11-pharmaceuticals-13-00303"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasoanaivo</surname><given-names>P.</given-names></name></person-group><article-title>Rain Forests of Madagascar: Sources of Industrial and Medicinal Plants</article-title><source>Ambio</source><year>1990</year><volume>19</volume><fpage>421</fpage><lpage>424</lpage></element-citation></ref><ref id="B12-pharmaceuticals-13-00303"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Gantait</surname><given-names>S.</given-names></name></person-group><article-title>Biotechnological advancements in <italic>Catharanthus roseus</italic> (L.) G. Don</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2020</year><volume>104</volume><fpage>4811</fpage><lpage>4835</lpage><pub-id pub-id-type="doi">10.1007/s00253-020-10592-1</pub-id><pub-id pub-id-type="pmid">32303816</pub-id></element-citation></ref><ref id="B13-pharmaceuticals-13-00303"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>P.</given-names></name><name><surname>Sharaf-Eldin</surname><given-names>M.</given-names></name></person-group><article-title>Limited Production Of Plant Derived Anticancer Drugs Vinblastine and Vincristine</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><pub-id pub-id-type="doi">10.1055/s-0036-1578706</pub-id></element-citation></ref><ref id="B14-pharmaceuticals-13-00303"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garot</surname><given-names>E.</given-names></name><name><surname>Jo&#x000eb;t</surname><given-names>T.</given-names></name><name><surname>Combes</surname><given-names>M.-C.</given-names></name><name><surname>Lashermes</surname><given-names>P.</given-names></name></person-group><article-title>Genetic diversity and population divergences of an indigenous tree (Coffea mauritiana) in Reunion Island: Role of climatic and geographical factors</article-title><source>Heredity (Edinb).</source><year>2019</year><volume>122</volume><fpage>833</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1038/s41437-018-0168-9</pub-id><?supplied-pmid 30478354?><pub-id pub-id-type="pmid">30478354</pub-id></element-citation></ref><ref id="B15-pharmaceuticals-13-00303"><label>15.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Baider</surname><given-names>C.</given-names></name><name><surname>Florens</surname><given-names>F.B.V.</given-names></name><name><surname>Baret</surname><given-names>S.</given-names></name><name><surname>Beaver</surname><given-names>K.</given-names></name><name><surname>Matatiken</surname><given-names>D.</given-names></name><name><surname>Strasberg</surname><given-names>D.</given-names></name><name><surname>Kueffer</surname><given-names>C.</given-names></name></person-group><article-title>Status of plant conservation in oceanic islands of the Western Indian Ocean</article-title><source>Proceedings of the 4th Global Botanic Gardens Congress</source><conf-loc>Dublin, Ireland</conf-loc><conf-date>13&#x02013;18 June 2010</conf-date><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="B16-pharmaceuticals-13-00303"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rummun</surname><given-names>N.</given-names></name><name><surname>Neergheen-Bhujun</surname><given-names>V.S.</given-names></name><name><surname>Pynee</surname><given-names>K.B.</given-names></name><name><surname>Baider</surname><given-names>C.</given-names></name><name><surname>Bahorun</surname><given-names>T.</given-names></name></person-group><article-title>The role of endemic plants in Mauritian traditional medicine&#x02014;Potential therapeutic benefits or placebo effect?</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>213</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.10.006</pub-id><?supplied-pmid 29030263?><pub-id pub-id-type="pmid">29030263</pub-id></element-citation></ref><ref id="B17-pharmaceuticals-13-00303"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphreys</surname><given-names>A.M.</given-names></name><name><surname>Govaerts</surname><given-names>R.</given-names></name><name><surname>Ficinski</surname><given-names>S.Z.</given-names></name><name><surname>Nic Lughadha</surname><given-names>E.</given-names></name><name><surname>Vorontsova</surname><given-names>M.S.</given-names></name></person-group><article-title>Global dataset shows geography and life form predict modern plant extinction and rediscovery</article-title><source>Nat. Ecol. Evol.</source><year>2019</year><volume>3</volume><fpage>1043</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1038/s41559-019-0906-2</pub-id><?supplied-pmid 31182811?><pub-id pub-id-type="pmid">31182811</pub-id></element-citation></ref><ref id="B18-pharmaceuticals-13-00303"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>W.</given-names></name></person-group><article-title><italic>Terminalia benzoin</italic> ssp. benzoin. The IUCN Red List of Threatened Species</article-title><year>1998</year><volume>8235</volume><elocation-id>e.T30745A9575875</elocation-id><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.iucnredlist.org/species/30745/9575875">https://www.iucnredlist.org/species/30745/9575875</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-12">(accessed on 12 October 2020)</date-in-citation></element-citation></ref><ref id="B19-pharmaceuticals-13-00303"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mileo</surname><given-names>A.M.</given-names></name><name><surname>Miccadei</surname><given-names>S.</given-names></name></person-group><article-title>Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies</article-title><source>Oxid. Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1155/2016/6475624</pub-id></element-citation></ref><ref id="B20-pharmaceuticals-13-00303"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Reale</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>H.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Tejada</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Z.-J.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name></person-group><article-title>Anti-cancer effects of polyphenols via targeting p53 signaling pathway: Updates and future directions</article-title><source>Biotechnol. Adv.</source><year>2020</year><volume>38</volume><fpage>107385</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.04.007</pub-id><pub-id pub-id-type="pmid">31004736</pub-id></element-citation></ref><ref id="B21-pharmaceuticals-13-00303"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azqueta</surname><given-names>A.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name></person-group><article-title>Polyphenols and DNA Damage: A Mixed Blessing</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>785</elocation-id><pub-id pub-id-type="doi">10.3390/nu8120785</pub-id></element-citation></ref><ref id="B22-pharmaceuticals-13-00303"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedzwiecki</surname><given-names>A.</given-names></name><name><surname>Roomi</surname><given-names>M.W.</given-names></name><name><surname>Kalinovsky</surname><given-names>T.</given-names></name><name><surname>Rath</surname><given-names>M.</given-names></name></person-group><article-title>Anticancer efficacy of polyphenols and their combinations</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>552</elocation-id><pub-id pub-id-type="doi">10.3390/nu8090552</pub-id></element-citation></ref><ref id="B23-pharmaceuticals-13-00303"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Page</surname><given-names>W.</given-names></name><name><surname>D&#x02019;Argent</surname><given-names>G.</given-names></name></person-group><source>A vegetation Survey of Mauritius (Indian Ocean) to Identify Priority Rainforest Areas for Conservation Management</source><comment>IUCN/MWF Report</comment><publisher-name>Mauritius Wildlife Foundation</publisher-name><publisher-loc>Vacoas-Phoenix, Mauritius</publisher-loc><year>1997</year></element-citation></ref><ref id="B24-pharmaceuticals-13-00303"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apel</surname><given-names>C.</given-names></name><name><surname>Bignon</surname><given-names>J.</given-names></name><name><surname>Garcia-Alvarez</surname><given-names>M.C.</given-names></name><name><surname>Ciccone</surname><given-names>S.</given-names></name><name><surname>Clerc</surname><given-names>P.</given-names></name><name><surname>Grondin</surname><given-names>I.</given-names></name><name><surname>Girard-Valenciennes</surname><given-names>E.</given-names></name><name><surname>Smadja</surname><given-names>J.</given-names></name><name><surname>Lopes</surname><given-names>P.</given-names></name><name><surname>Fr&#x000e9;d&#x000e9;rich</surname><given-names>M.</given-names></name><etal/></person-group><article-title>N-myristoyltransferases inhibitory activity of ellagitannins from <italic>Terminalia bentzo&#x000eb;</italic> (L.) L. f. subsp. bentzo&#x000eb;</article-title><source>Fitoterapia</source><year>2018</year><volume>131</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2018.10.014</pub-id><?supplied-pmid 30342177?><pub-id pub-id-type="pmid">30342177</pub-id></element-citation></ref><ref id="B25-pharmaceuticals-13-00303"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latt&#x000e9;</surname><given-names>K.P.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name><name><surname>Venkatraman</surname><given-names>M.S.</given-names></name><name><surname>Kolodziej</surname><given-names>H.</given-names></name></person-group><article-title>O-galloyl-C-glycosylflavones from Pelargonium reniforme</article-title><source>Phytochemistry</source><year>2002</year><volume>59</volume><fpage>419</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(01)00403-4</pub-id><pub-id pub-id-type="pmid">11830160</pub-id></element-citation></ref><ref id="B26-pharmaceuticals-13-00303"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Katerere</surname><given-names>D.R.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>Seidel</surname><given-names>V.</given-names></name></person-group><article-title>Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma</article-title><source>Fitoterapia</source><year>2009</year><volume>80</volume><fpage>369</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.05.006</pub-id><pub-id pub-id-type="pmid">19446614</pub-id></element-citation></ref><ref id="B27-pharmaceuticals-13-00303"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzouk</surname><given-names>M.S.A.</given-names></name><name><surname>El-Toumy</surname><given-names>S.A.A.</given-names></name><name><surname>Moharram</surname><given-names>F.A.</given-names></name></person-group><article-title>Pharmacologically Active Ellagitannins from Terminalia myriocarpa</article-title><source>Planta Med.</source><year>2002</year><volume>68</volume><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1055/s-2002-32549</pub-id><pub-id pub-id-type="pmid">12094296</pub-id></element-citation></ref><ref id="B28-pharmaceuticals-13-00303"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>NONAKA</surname><given-names>G.-I.</given-names></name><name><surname>NISHIOKA</surname><given-names>I.</given-names></name></person-group><article-title>Tannins and related compounds. XLII. Isolation and characterization of four new hydrolyzable tannins, terflavins A and B, tergallagin and tercatain from the leaves of <italic>Terminalia catappa</italic> L.</article-title><source>Chem. Pharm. Bull. (Tokyo)</source><year>1986</year><volume>34</volume><fpage>1039</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1248/cpb.34.1039</pub-id></element-citation></ref><ref id="B29-pharmaceuticals-13-00303"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubu</surname><given-names>O.F.</given-names></name><name><surname>Adebayo</surname><given-names>A.H.</given-names></name><name><surname>Dokunmu</surname><given-names>T.M.</given-names></name><name><surname>Zhang</surname><given-names>Y.-J.</given-names></name><name><surname>Iweala</surname><given-names>E.E.J.</given-names></name></person-group><article-title>Cytotoxic Effects of Compounds Isolated from Ricinodendron heudelotii</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>145</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24010145</pub-id></element-citation></ref><ref id="B30-pharmaceuticals-13-00303"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>V.</given-names></name></person-group><article-title>Back to Nature: Extinction of Medicinal Plants Threatens Drug Discovery</article-title><source>JNCI J. Natl. Cancer Inst.</source><year>2008</year><volume>100</volume><fpage>838</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1093/jnci/djn199</pub-id><?supplied-pmid 18544733?><pub-id pub-id-type="pmid">18544733</pub-id></element-citation></ref><ref id="B31-pharmaceuticals-13-00303"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>U.</given-names></name><name><surname>Jacobo-Herrera</surname><given-names>N.</given-names></name><name><surname>Altemimi</surname><given-names>A.</given-names></name><name><surname>Lakhssassi</surname><given-names>N.</given-names></name></person-group><article-title>A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of biocompatible drug discovery</article-title><source>Metabolites</source><year>2019</year><volume>9</volume><elocation-id>258</elocation-id><pub-id pub-id-type="doi">10.3390/metabo9110258</pub-id></element-citation></ref><ref id="B32-pharmaceuticals-13-00303"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreyra</surname><given-names>F.M.L.</given-names></name><name><surname>Rius</surname><given-names>S.P.</given-names></name><name><surname>Casati</surname><given-names>P.</given-names></name></person-group><article-title>Flavonoids: Biosynthesis, biological functions, and biotechnological applications</article-title><source>Front. Plant Sci.</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.3389/fpls.2012.00222</pub-id><pub-id pub-id-type="pmid">22645563</pub-id></element-citation></ref><ref id="B33-pharmaceuticals-13-00303"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bahorun</surname><given-names>T.</given-names></name><name><surname>Ramful-Baboolall</surname><given-names>D.</given-names></name><name><surname>Neergheen-Bhujun</surname><given-names>V.</given-names></name><name><surname>Aruoma</surname><given-names>O.I.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Tarnus</surname><given-names>E.</given-names></name><name><surname>Da Silva</surname><given-names>C.R.</given-names></name><name><surname>Rondeau</surname><given-names>P.</given-names></name><name><surname>Bourdon</surname><given-names>E.</given-names></name></person-group><article-title>Phytophenolic Nutrients in Citrus: Biochemical and Molecular Evidence</article-title><source>Advances in Citrus Nutrition</source><person-group person-group-type="editor"><name><surname>Srivastava</surname><given-names>A.K.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Dordrecht, The Netherlands</publisher-loc><year>2012</year><volume>Volume 9789400741</volume><fpage>25</fpage><lpage>40</lpage><isbn>978-94-007-4170-6</isbn></element-citation></ref><ref id="B34-pharmaceuticals-13-00303"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perillo</surname><given-names>B.</given-names></name><name><surname>Di Donato</surname><given-names>M.</given-names></name><name><surname>Pezone</surname><given-names>A.</given-names></name><name><surname>Di Zazzo</surname><given-names>E.</given-names></name><name><surname>Giovannelli</surname><given-names>P.</given-names></name><name><surname>Galasso</surname><given-names>G.</given-names></name><name><surname>Castoria</surname><given-names>G.</given-names></name><name><surname>Migliaccio</surname><given-names>A.</given-names></name></person-group><article-title>ROS in cancer therapy: The bright side of the moon</article-title><source>Exp. Mol. Med.</source><year>2020</year><volume>52</volume><fpage>192</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/s12276-020-0384-2</pub-id><pub-id pub-id-type="pmid">32060354</pub-id></element-citation></ref><ref id="B35-pharmaceuticals-13-00303"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M.A.</given-names></name></person-group><article-title>Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature&#x02019;s Bounty</article-title><source>Biomed. Res. Int.</source><year>2020</year><volume>2020</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1155/2020/8602879</pub-id><?supplied-pmid 32076618?><pub-id pub-id-type="pmid">32076618</pub-id></element-citation></ref><ref id="B36-pharmaceuticals-13-00303"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.-Y.</given-names></name><name><surname>Chan</surname><given-names>S.-W.</given-names></name><name><surname>Guo</surname><given-names>D.-J.</given-names></name><name><surname>Yu</surname><given-names>P.H.-F.</given-names></name></person-group><article-title>Correlation Between Antioxidative Power and Anticancer Activity in Herbs from Traditional Chinese Medicine Formulae with Anticancer Therapeutic Effect</article-title><source>Pharm. Biol.</source><year>2007</year><volume>45</volume><fpage>541</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1080/13880200701498879</pub-id></element-citation></ref><ref id="B37-pharmaceuticals-13-00303"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sammar</surname><given-names>M.</given-names></name><name><surname>Abu-Farich</surname><given-names>B.</given-names></name><name><surname>Rayan</surname><given-names>I.</given-names></name><name><surname>Falah</surname><given-names>M.</given-names></name><name><surname>Rayan</surname><given-names>A.</given-names></name></person-group><article-title>Correlation between cytotoxicity in cancer cells and free radical-scavenging activity: In-vitro evaluation of 57 medicinal and edible plant extracts</article-title><source>Oncol. Lett.</source><year>2019</year><volume>18</volume><fpage>6563</fpage><lpage>6571</lpage><pub-id pub-id-type="doi">10.3892/ol.2019.11054</pub-id><pub-id pub-id-type="pmid">31819777</pub-id></element-citation></ref><ref id="B38-pharmaceuticals-13-00303"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snezhkina</surname><given-names>A.V.</given-names></name><name><surname>Kudryavtseva</surname><given-names>A.V.</given-names></name><name><surname>Kardymon</surname><given-names>O.L.</given-names></name><name><surname>Savvateeva</surname><given-names>M.V.</given-names></name><name><surname>Melnikova</surname><given-names>N.V.</given-names></name><name><surname>Krasnov</surname><given-names>G.S.</given-names></name><name><surname>Dmitriev</surname><given-names>A.A.</given-names></name></person-group><article-title>ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells</article-title><source>Oxid. Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1155/2019/6175804</pub-id></element-citation></ref><ref id="B39-pharmaceuticals-13-00303"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>V.</given-names></name><name><surname>Tuli</surname><given-names>H.S.</given-names></name><name><surname>Varol</surname><given-names>A.</given-names></name><name><surname>Thakral</surname><given-names>F.</given-names></name><name><surname>Yerer</surname><given-names>M.B.</given-names></name><name><surname>Sak</surname><given-names>K.</given-names></name><name><surname>Varol</surname><given-names>M.</given-names></name><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>M.A.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>735</elocation-id><pub-id pub-id-type="doi">10.3390/biom9110735</pub-id></element-citation></ref><ref id="B40-pharmaceuticals-13-00303"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panieri</surname><given-names>E.</given-names></name><name><surname>Santoro</surname><given-names>M.M.</given-names></name></person-group><article-title>Ros homeostasis and metabolism: A dangerous liason in cancer cells</article-title><source>Cell Death Dis.</source><year>2016</year><volume>7</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/cddis.2016.105</pub-id><?supplied-pmid 27277675?><pub-id pub-id-type="pmid">27277675</pub-id></element-citation></ref><ref id="B41-pharmaceuticals-13-00303"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorrini</surname><given-names>C.</given-names></name><name><surname>Harris</surname><given-names>I.S.</given-names></name><name><surname>Mak</surname><given-names>T.W.</given-names></name></person-group><article-title>Modulation of oxidative stress as an anticancer strategy</article-title><source>Nat. Rev. Drug Discov.</source><year>2013</year><volume>12</volume><fpage>931</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1038/nrd4002</pub-id><pub-id pub-id-type="pmid">24287781</pub-id></element-citation></ref><ref id="B42-pharmaceuticals-13-00303"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proch&#x000e1;zkov&#x000e1;</surname><given-names>D.</given-names></name><name><surname>Bou&#x00161;ov&#x000e1;</surname><given-names>I.</given-names></name><name><surname>Wilhelmov&#x000e1;</surname><given-names>N.</given-names></name></person-group><article-title>Antioxidant and prooxidant properties of flavonoids</article-title><source>Fitoterapia</source><year>2011</year><volume>82</volume><fpage>513</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2011.01.018</pub-id><pub-id pub-id-type="pmid">21277359</pub-id></element-citation></ref><ref id="B43-pharmaceuticals-13-00303"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moulisha</surname><given-names>B.</given-names></name><name><surname>Ashok Kumar</surname><given-names>G.</given-names></name><name><surname>Pallab Kanti</surname><given-names>H.</given-names></name></person-group><article-title>Anti-leishmanial and anti-cancer activities of a pentacyclic triterpenoid isolated from the leaves of Terminalia arjuna Combretaceae</article-title><source>Trop. J. Pharm. Res.</source><year>2010</year><volume>9</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v9i2.53700</pub-id></element-citation></ref><ref id="B44-pharmaceuticals-13-00303"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankara</surname><given-names>R.B.</given-names></name><name><surname>Ramachandra</surname><given-names>Y.</given-names></name><name><surname>Rajan</surname><given-names>S.S.</given-names></name><name><surname>Sujan Ganapathy</surname><given-names>P.</given-names></name><name><surname>Yarla</surname><given-names>N.</given-names></name><name><surname>Richard</surname><given-names>S.</given-names></name><name><surname>Dhananjaya</surname><given-names>B.</given-names></name></person-group><article-title>Evaluating the anticancer potential of ethanolic gall extract of Terminalia chebula (Gaertn.) Retz. (combretaceae)</article-title><source>Pharmacogn. Res.</source><year>2016</year><volume>8</volume><fpage>209</fpage><pub-id pub-id-type="doi">10.4103/0974-8490.182919</pub-id></element-citation></ref><ref id="B45-pharmaceuticals-13-00303"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanehbandi</surname><given-names>D.</given-names></name><name><surname>Zarredar</surname><given-names>H.</given-names></name><name><surname>Asadi</surname><given-names>M.</given-names></name><name><surname>Zafari</surname><given-names>V.</given-names></name><name><surname>Esmaeili</surname><given-names>S.</given-names></name><name><surname>Seyedrezazadeh</surname><given-names>E.</given-names></name><name><surname>Soleimani</surname><given-names>Z.</given-names></name><name><surname>Sabagh Jadid</surname><given-names>H.</given-names></name><name><surname>Eyvazi</surname><given-names>S.</given-names></name><name><surname>Feyziniya</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Anticancer Impacts of Terminalia catappa Extract on SW480 Colorectal Neoplasm Cell Line</article-title><source>J. Gastrointest. Cancer</source><year>2019</year><pub-id pub-id-type="doi">10.1007/s12029-019-00349-z</pub-id><?supplied-pmid 31823219?><pub-id pub-id-type="pmid">31823219</pub-id></element-citation></ref><ref id="B46-pharmaceuticals-13-00303"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Silva</surname><given-names>A.</given-names></name><name><surname>Tavares-Carre&#x000f3;n</surname><given-names>F.</given-names></name><name><surname>Figueroa</surname><given-names>M.</given-names></name><name><surname>De la Torre-Zavala</surname><given-names>S.</given-names></name><name><surname>Gastelum-Arellanez</surname><given-names>A.</given-names></name><name><surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname><given-names>A.</given-names></name><name><surname>Gal&#x000e1;n-Wong</surname><given-names>L.J.</given-names></name><name><surname>Avil&#x000e9;s-Arnaut</surname><given-names>H.</given-names></name></person-group><article-title>Anticancer potential of Thevetia peruviana fruit methanolic extract</article-title><source>BMC Complement. Altern. Med.</source><year>2017</year><volume>17</volume><elocation-id>241</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-017-1727-y</pub-id><?supplied-pmid 28464893?><pub-id pub-id-type="pmid">28464893</pub-id></element-citation></ref><ref id="B47-pharmaceuticals-13-00303"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayarathna</surname><given-names>S.</given-names></name><name><surname>Sasidharan</surname><given-names>S.</given-names></name></person-group><article-title>Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2012</year><volume>2</volume><fpage>826</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60237-8</pub-id><pub-id pub-id-type="pmid">23569855</pub-id></element-citation></ref><ref id="B48-pharmaceuticals-13-00303"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzayans</surname><given-names>R.</given-names></name><name><surname>Andrais</surname><given-names>B.</given-names></name><name><surname>Murray</surname><given-names>D.</given-names></name></person-group><article-title>Viability Assessment Following Anticancer Treatment Requires Single-Cell Visualization</article-title><source>Cancers</source><year>2018</year><volume>10</volume><elocation-id>255</elocation-id><pub-id pub-id-type="doi">10.3390/cancers10080255</pub-id><?supplied-pmid 30071623?><pub-id pub-id-type="pmid">30071623</pub-id></element-citation></ref><ref id="B49-pharmaceuticals-13-00303"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahanban-Esfahlan</surname><given-names>R.</given-names></name><name><surname>Seidi</surname><given-names>K.</given-names></name><name><surname>Manjili</surname><given-names>M.H.</given-names></name><name><surname>Jahanban-Esfahlan</surname><given-names>A.</given-names></name><name><surname>Javaheri</surname><given-names>T.</given-names></name><name><surname>Zare</surname><given-names>P.</given-names></name></person-group><article-title>Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer</article-title><source>Cancers</source><year>2019</year><volume>11</volume><elocation-id>1207</elocation-id><pub-id pub-id-type="doi">10.3390/cancers11081207</pub-id><?supplied-pmid 31430951?><pub-id pub-id-type="pmid">31430951</pub-id></element-citation></ref><ref id="B50-pharmaceuticals-13-00303"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzayans</surname><given-names>R.</given-names></name><name><surname>Murray</surname><given-names>D.</given-names></name></person-group><article-title>Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1308</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21041308</pub-id></element-citation></ref><ref id="B51-pharmaceuticals-13-00303"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myint</surname><given-names>P.P.</given-names></name><name><surname>Dao</surname><given-names>T.T.P.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name></person-group><article-title>Anticancer Activity of Smallanthus sonchifolius Methanol Extract against Human Hepatocellular Carcinoma Cells</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3054</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24173054</pub-id></element-citation></ref><ref id="B52-pharmaceuticals-13-00303"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khorsandi</surname><given-names>K.</given-names></name><name><surname>Kianmehr</surname><given-names>Z.</given-names></name><name><surname>Hosseinmardi</surname><given-names>Z.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>R.</given-names></name></person-group><article-title>Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis</article-title><source>Cancer Cell Int.</source><year>2020</year><volume>20</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/s12935-020-1100-y</pub-id><pub-id pub-id-type="pmid">31956296</pub-id></element-citation></ref><ref id="B53-pharmaceuticals-13-00303"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afsar</surname><given-names>T.</given-names></name><name><surname>Trembley</surname><given-names>J.H.</given-names></name><name><surname>Salomon</surname><given-names>C.E.</given-names></name><name><surname>Razak</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>M.R.</given-names></name><name><surname>Ahmed</surname><given-names>K.</given-names></name></person-group><article-title>Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><pub-id pub-id-type="doi">10.1038/srep23077</pub-id></element-citation></ref><ref id="B54-pharmaceuticals-13-00303"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.T.</given-names></name></person-group><article-title>Secondary necrosis: The natural outcome of the complete apoptotic program</article-title><source>FEBS Lett.</source><year>2010</year><volume>584</volume><fpage>4491</fpage><lpage>4499</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2010.10.046</pub-id><pub-id pub-id-type="pmid">20974143</pub-id></element-citation></ref><ref id="B55-pharmaceuticals-13-00303"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Ju</surname><given-names>M.K.</given-names></name><name><surname>Jeon</surname><given-names>H.M.</given-names></name><name><surname>Jeong</surname><given-names>E.K.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Kim</surname><given-names>C.H.</given-names></name><name><surname>Park</surname><given-names>H.G.</given-names></name><name><surname>Han</surname><given-names>S.I.</given-names></name><name><surname>Kang</surname><given-names>H.S.</given-names></name></person-group><article-title>Regulation of Tumor Progression by Programmed Necrosis</article-title><source>Oxid. Med. Cell. Longev.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1155/2018/3537471</pub-id><?supplied-pmid 29636841?><pub-id pub-id-type="pmid">29636841</pub-id></element-citation></ref><ref id="B56-pharmaceuticals-13-00303"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edderkaoui</surname><given-names>M.</given-names></name><name><surname>Odinokova</surname><given-names>I.</given-names></name><name><surname>Ohno</surname><given-names>I.</given-names></name><name><surname>Gukovsky</surname><given-names>I.</given-names></name><name><surname>Go</surname><given-names>V.L.W.</given-names></name><name><surname>Pandol</surname><given-names>S.J.</given-names></name><name><surname>Gukovskaya</surname><given-names>A.S.</given-names></name></person-group><article-title>Ellagic acid induces apoptosis through inhibition of nuclear factor kB in pancreatic cancer cells</article-title><source>World J. Gastroenterol.</source><year>2008</year><volume>14</volume><fpage>3672</fpage><pub-id pub-id-type="doi">10.3748/wjg.14.3672</pub-id><?supplied-pmid 18595134?><pub-id pub-id-type="pmid">18595134</pub-id></element-citation></ref><ref id="B57-pharmaceuticals-13-00303"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace Nirmala</surname><given-names>J.</given-names></name><name><surname>Evangeline Celsia</surname><given-names>S.</given-names></name><name><surname>Swaminathan</surname><given-names>A.</given-names></name><name><surname>Narendhirakannan</surname><given-names>R.T.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name></person-group><article-title>Cytotoxicity and apoptotic cell death induced by Vitis vinifera peel and seed extracts in A431 skin cancer cells</article-title><source>Cytotechnology</source><year>2018</year><volume>70</volume><fpage>537</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1007/s10616-017-0125-0</pub-id><?supplied-pmid 28983752?><pub-id pub-id-type="pmid">28983752</pub-id></element-citation></ref><ref id="B58-pharmaceuticals-13-00303"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahassni</surname><given-names>S.H.</given-names></name><name><surname>Al-Reemi</surname><given-names>R.M.</given-names></name></person-group><article-title>Apoptosis and necrosis of human breast cancer cells by an aqueous extract of garden cress (Lepidium sativum) seeds</article-title><source>Saudi J. Biol. Sci.</source><year>2013</year><volume>20</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2012.12.002</pub-id><?supplied-pmid 23961228?><pub-id pub-id-type="pmid">23961228</pub-id></element-citation></ref><ref id="B59-pharmaceuticals-13-00303"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>H.</given-names></name><name><surname>Szyjka</surname><given-names>A.</given-names></name><name><surname>Paliszkiewicz</surname><given-names>K.</given-names></name><name><surname>Barg</surname><given-names>E.</given-names></name></person-group><article-title>Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells</article-title><source>Oxid. Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2019/6793957</pub-id><?supplied-pmid 31485297?><pub-id pub-id-type="pmid">31485297</pub-id></element-citation></ref><ref id="B60-pharmaceuticals-13-00303"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells</article-title><source>Oncol. Rep.</source><year>2019</year><volume>41</volume><fpage>765</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6864</pub-id><pub-id pub-id-type="pmid">30431140</pub-id></element-citation></ref><ref id="B61-pharmaceuticals-13-00303"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustine</surname><given-names>D.</given-names></name><name><surname>Rao</surname><given-names>R.S.</given-names></name><name><surname>Anbu</surname><given-names>J.</given-names></name><name><surname>Chidambara Murthy</surname><given-names>K.N.</given-names></name></person-group><article-title>In vitro cytotoxic and apoptotic induction effect of earthworm coelomic fluid of Eudrilus eugeniae, Eisenia foetida, and Perionyx excavatus on human oral squamous cell carcinoma-9 cell line</article-title><source>Toxicol. Rep.</source><year>2019</year><volume>6</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2019.04.005</pub-id><pub-id pub-id-type="pmid">31061813</pub-id></element-citation></ref><ref id="B62-pharmaceuticals-13-00303"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P.-L.</given-names></name><name><surname>Hsu</surname><given-names>Y.-L.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Chang</surname><given-names>J.-K.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group><article-title>Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn</article-title><source>Anticancer Drugs</source><year>2005</year><volume>16</volume><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1097/00001813-200504000-00007</pub-id><pub-id pub-id-type="pmid">15746577</pub-id></element-citation></ref><ref id="B63-pharmaceuticals-13-00303"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Pferschy-Wenzig</surname><given-names>E.-M.</given-names></name><name><surname>Linder</surname><given-names>T.</given-names></name><name><surname>Wawrosch</surname><given-names>C.</given-names></name><name><surname>Uhrin</surname><given-names>P.</given-names></name><name><surname>Temml</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Schwaiger</surname><given-names>S.</given-names></name><name><surname>Heiss</surname><given-names>E.H.</given-names></name><etal/></person-group><article-title>Discovery and resupply of pharmacologically active plant-derived natural products: A review</article-title><source>Biotechnol. Adv.</source><year>2015</year><volume>33</volume><fpage>1582</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2015.08.001</pub-id><pub-id pub-id-type="pmid">26281720</pub-id></element-citation></ref><ref id="B64-pharmaceuticals-13-00303"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikezie</surname><given-names>P.C.</given-names></name><name><surname>Ibegbulem</surname><given-names>C.O.</given-names></name><name><surname>Mbagwu</surname><given-names>F.N.</given-names></name></person-group><article-title>Bioactive principles from medicinal plants</article-title><source>Res. J. Phytochem.</source><year>2015</year><volume>9</volume><fpage>88</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.3923/rjphyto.2015.88.115</pub-id></element-citation></ref><ref id="B65-pharmaceuticals-13-00303"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katiyar</surname><given-names>C.</given-names></name><name><surname>Kanjilal</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Katiyar</surname><given-names>S.</given-names></name></person-group><article-title>Drug discovery from plant sources: An integrated approach</article-title><source>AYU (An Int. Q. J. Res. Ayurveda)</source><year>2012</year><volume>33</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.4103/0974-8520.100295</pub-id><?supplied-pmid 23049178?><pub-id pub-id-type="pmid">23049178</pub-id></element-citation></ref><ref id="B66-pharmaceuticals-13-00303"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>Preparation of Botanical Samples for Biomedical Research</article-title><source>Endocr. Metab. Immune Disord. Targets</source><year>2008</year><volume>8</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.2174/187153008784534358</pub-id><?supplied-pmid 18537697?><pub-id pub-id-type="pmid">18537697</pub-id></element-citation></ref><ref id="B67-pharmaceuticals-13-00303"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Hou</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name></person-group><article-title>Punicalagin and ellagic acid from pomegranate peel induce apoptosis and inhibits proliferation in human HepG2 hepatoma cells through targeting mitochondria</article-title><source>Food Agric. Immunol.</source><year>2019</year><volume>30</volume><fpage>897</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1080/09540105.2019.1642857</pub-id></element-citation></ref><ref id="B68-pharmaceuticals-13-00303"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Bao</surname><given-names>J.</given-names></name><name><surname>Guan</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-&#x003ba;B signaling pathway</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>103</volume><fpage>490</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.074</pub-id><pub-id pub-id-type="pmid">29677534</pub-id></element-citation></ref><ref id="B69-pharmaceuticals-13-00303"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.M.</given-names></name><name><surname>Min</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>B.S.</given-names></name><name><surname>Hong</surname><given-names>S.S.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>L.</given-names></name></person-group><article-title>Therapeutic Effects of Punicalagin Against Ovarian Carcinoma Cells in Association with &#x003b2;-Catenin Signaling Inhibition</article-title><source>Int. J. Gynecol. Cancer</source><year>2016</year><volume>26</volume><fpage>1557</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1097/IGC.0000000000000805</pub-id><?supplied-pmid 27540692?><pub-id pub-id-type="pmid">27540692</pub-id></element-citation></ref><ref id="B70-pharmaceuticals-13-00303"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceci</surname><given-names>C.</given-names></name><name><surname>Lacal</surname><given-names>P.M.</given-names></name><name><surname>Tentori</surname><given-names>L.</given-names></name><name><surname>De Martino</surname><given-names>M.G.</given-names></name><name><surname>Miano</surname><given-names>R.</given-names></name><name><surname>Graziani</surname><given-names>G.</given-names></name></person-group><article-title>Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1756</elocation-id><pub-id pub-id-type="doi">10.3390/nu10111756</pub-id></element-citation></ref><ref id="B71-pharmaceuticals-13-00303"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Carranza</surname><given-names>J.</given-names></name><name><surname>Alvarez</surname><given-names>L.</given-names></name><name><surname>Marquina-Bahena</surname><given-names>S.</given-names></name><name><surname>Salas-Vidal</surname><given-names>E.</given-names></name><name><surname>Cuevas</surname><given-names>V.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>E.</given-names></name><name><surname>Veloz G.</surname><given-names>R.</given-names></name><name><surname>Carraz</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez-Maya</surname><given-names>L.</given-names></name></person-group><article-title>Phenolic Compounds Isolated from Caesalpinia coriaria Induce S and G2/M Phase Cell Cycle Arrest Differentially and Trigger Cell Death by Interfering with Microtubule Dynamics in Cancer Cell Lines</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>666</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22040666</pub-id><?supplied-pmid 28441723?><pub-id pub-id-type="pmid">28441723</pub-id></element-citation></ref><ref id="B72-pharmaceuticals-13-00303"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson-ajinwo</surname><given-names>O.R.</given-names></name><name><surname>Richardson</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.-W.</given-names></name></person-group><article-title>Cytotoxic effects of stem bark extracts and pure compounds from Margaritaria discoidea on human ovarian cancer cell lines</article-title><source>Phytomedicine</source><year>2015</year><volume>22</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2014.09.008</pub-id><pub-id pub-id-type="pmid">25636863</pub-id></element-citation></ref><ref id="B73-pharmaceuticals-13-00303"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rummun</surname><given-names>N.</given-names></name><name><surname>Somanah</surname><given-names>J.</given-names></name><name><surname>Ramsaha</surname><given-names>S.</given-names></name><name><surname>Bahorun</surname><given-names>T.</given-names></name><name><surname>Neergheen-Bhujun</surname><given-names>V.S.</given-names></name></person-group><article-title>Bioactivity of Nonedible Parts of Punica granatum L.: A Potential Source of Functional Ingredients</article-title><source>Int. J. Food Sci.</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2013/602312</pub-id></element-citation></ref><ref id="B74-pharmaceuticals-13-00303"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rummun</surname><given-names>N.</given-names></name><name><surname>Hughes</surname><given-names>R.E.</given-names></name><name><surname>Beesoo</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>W.W.</given-names></name><name><surname>Aldulaimi</surname><given-names>O.</given-names></name><name><surname>Macleod</surname><given-names>K.G.</given-names></name><name><surname>Bahorun</surname><given-names>T.</given-names></name><name><surname>Carragher</surname><given-names>N.O.</given-names></name><name><surname>Kagansky</surname><given-names>A.</given-names></name><name><surname>Neergheen-Bhujun</surname><given-names>V.S.</given-names></name></person-group><article-title>Mauritian Endemic Medicinal Plant Extracts Induce G2/M Phase Cell Cycle Arrest and Growth Inhibition of Oesophageal Squamous Cell Carcinoma in Vitro</article-title><source>Acta Nat.</source><year>2019</year><volume>11</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.32607/20758251-2019-11-1-81-90</pub-id></element-citation></ref><ref id="B75-pharmaceuticals-13-00303"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramful</surname><given-names>D.</given-names></name><name><surname>Tarnus</surname><given-names>E.</given-names></name><name><surname>Rondeau</surname><given-names>P.</given-names></name><name><surname>Robert Da Silva</surname><given-names>C.</given-names></name><name><surname>Bahorun</surname><given-names>T.</given-names></name><name><surname>Bourdon</surname><given-names>E.</given-names></name></person-group><article-title>Citrus fruit extracts reduce advanced glycation end products (AGEs)- and H2O2 -induced oxidative stress in human adipocytes</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>11119</fpage><lpage>11129</lpage><pub-id pub-id-type="doi">10.1021/jf102762s</pub-id><?supplied-pmid 20882960?><pub-id pub-id-type="pmid">20882960</pub-id></element-citation></ref><ref id="B76-pharmaceuticals-13-00303"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Dabbagh</surname><given-names>B.</given-names></name><name><surname>Elhaty</surname><given-names>I.A.</given-names></name><name><surname>Al Hrout</surname><given-names>A.</given-names></name><name><surname>Al Sakkaf</surname><given-names>R.</given-names></name><name><surname>El-Awady</surname><given-names>R.</given-names></name><name><surname>Ashraf</surname><given-names>S.S.</given-names></name><name><surname>Amin</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant and anticancer activities of Trigonella foenum-graecum, Cassia acutifolia and Rhazya stricta</article-title><source>BMC Complement. Altern. Med.</source><year>2018</year><volume>18</volume><elocation-id>240</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-018-2285-7</pub-id><?supplied-pmid 30134897?><pub-id pub-id-type="pmid">30134897</pub-id></element-citation></ref><ref id="B77-pharmaceuticals-13-00303"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franken</surname><given-names>N.A.P.</given-names></name><name><surname>Rodermond</surname><given-names>H.M.</given-names></name><name><surname>Stap</surname><given-names>J.</given-names></name><name><surname>Haveman</surname><given-names>J.</given-names></name><name><surname>van Bree</surname><given-names>C.</given-names></name></person-group><article-title>Clonogenic assay of cells in vitro</article-title><source>Nat. Protoc.</source><year>2006</year><volume>1</volume><fpage>2315</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.339</pub-id><pub-id pub-id-type="pmid">17406473</pub-id></element-citation></ref><ref id="B78-pharmaceuticals-13-00303"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A.R.</given-names></name></person-group><article-title>The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations</article-title><source>Mol. Biotechnol.</source><year>2004</year><volume>26</volume><fpage>249</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1385/MB:26:3:249</pub-id><pub-id pub-id-type="pmid">15004294</pub-id></element-citation></ref><ref id="B79-pharmaceuticals-13-00303"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaji</surname><given-names>C.</given-names></name><name><surname>Jord&#x000e3;o</surname><given-names>B.</given-names></name><name><surname>Ribeiro</surname><given-names>L.</given-names></name><name><surname>Eira</surname><given-names>A.</given-names></name><name><surname>C&#x000f3;lus</surname><given-names>I.</given-names></name></person-group><article-title>Genotoxicity and antigenotoxicity assessment of shiitake (Lentinula edodes (Berkeley) Pegler) using the Comet assay</article-title><source>Genet. Mol. Biol.</source><year>2004</year><volume>27</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1590/S1415-47572004000100018</pub-id></element-citation></ref><ref id="B80-pharmaceuticals-13-00303"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catan</surname><given-names>A.</given-names></name><name><surname>Turpin</surname><given-names>C.</given-names></name><name><surname>Diotel</surname><given-names>N.</given-names></name><name><surname>Patche</surname><given-names>J.</given-names></name><name><surname>Guerin-Dubourg</surname><given-names>A.</given-names></name><name><surname>Debussche</surname><given-names>X.</given-names></name><name><surname>Bourdon</surname><given-names>E.</given-names></name><name><surname>Ah-You</surname><given-names>N.</given-names></name><name><surname>Le Moullec</surname><given-names>N.</given-names></name><name><surname>Besnard</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Aging and glycation promote erythrocyte phagocytosis by human endothelial cells: Potential impact in atherothrombosis under diabetic conditions</article-title><source>Atherosclerosis</source><year>2019</year><volume>291</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2019.10.015</pub-id><pub-id pub-id-type="pmid">31704555</pub-id></element-citation></ref><ref id="B81-pharmaceuticals-13-00303"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>J.</given-names></name><name><surname>Cederbaum</surname><given-names>A.I.</given-names></name></person-group><article-title>Cycloheximide Protects HepG2 Cells from Serum Withdrawal-Induced Apoptosis by Decreasing p53 and Phosphorylated p53 Levels</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2006</year><volume>319</volume><fpage>1435</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1124/jpet.106.110007</pub-id><pub-id pub-id-type="pmid">16971506</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pharmaceuticals-13-00303-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>HepG2 cells were treated with the indicated concentrations (&#x000b5;g/mL) of test extracts for 48 h and subsequently allowed to grow into colonies for 14 days. After 14 days, the colonies were stained with 0.1% crystal violet and the images of the wells were captured using a digital camera. The colonies were counted using Image J software. Each experiment was performed three times. Asterisks represent significant differences between extract treatments and untreated control, **** <italic>p</italic> &#x02264; 0.0001.</p></caption><graphic xlink:href="pharmaceuticals-13-00303-g001"/></fig><fig id="pharmaceuticals-13-00303-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of <italic>Terminalia bentzo&#x000eb;</italic> and etoposide on HepG2 cells as analyzed by flow cytometry. (<bold>A</bold>) Annexin V-FITC/PI staining of HepG2 cells after 48 hours&#x02019; treatment and (<bold>B</bold>) cell cycle progression. Apoptosis and necrosis levels are expressed as percentage of the total cell population and given as mean &#x000b1; SD (<italic>n</italic> = 5). Percentage of cells in different phases (G0/G1, S and G2/M phases) are expressed as mean &#x000b1; SD (<italic>n</italic> = 3). Asterisks represent significant differences between test concentrations and dimethyl sulfoxide (DMSO) control. * <italic>p</italic> &#x02264; 0.05, ** <italic>p</italic> &#x02264; 0.01, *** <italic>p</italic> &#x02264; 0.001, **** <italic>p</italic> &#x02264; 0.0001.</p></caption><graphic xlink:href="pharmaceuticals-13-00303-g002a"/><graphic xlink:href="pharmaceuticals-13-00303-g002b"/></fig><fig id="pharmaceuticals-13-00303-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>MTT-guided fractionation of <italic>T. bentzo&#x000eb;</italic> extract cytotoxicity against HepG2 cells. Cmpd: Compound. Cmpd 1= &#x003b1; and &#x003b2;- Punicalagin; compd 2 = Isoterchebulin; compd 3 = Terflavin A; cmpd 4 = 3,4,6-trigalloyl-&#x003b2;-D-glucopyranose; cmpd 5 = 2&#x0201d;-<italic>O</italic>-galloyl-orientin; cmpd 6 = 2&#x0201d;-<italic>O</italic>-galloyl-isoorientin.</p></caption><graphic xlink:href="pharmaceuticals-13-00303-g003"/></fig><fig id="pharmaceuticals-13-00303-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structure of polyphenolic compounds (<bold>1</bold>&#x02013;<bold>8</bold>) identified in <italic>Terminalia bentzo&#x000eb;</italic> L. leaf extract.</p></caption><graphic xlink:href="pharmaceuticals-13-00303-g004"/></fig><table-wrap id="pharmaceuticals-13-00303-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t001_Table 1</object-id><label>Table 1</label><caption><p>The investigated Mascarene endemic plant species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vernacular Names</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ethnomedicinal Uses [<xref rid="B16-pharmaceuticals-13-00303" ref-type="bibr">16</xref>]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Collection Site</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Collection Date</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mauritius Herbarium Accession Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Yield</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Antirhea borbonica</italic> J.F.Gmel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rubiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bois lousteau, Bois d&#x02019;oiseau</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Astringent, diarrhea, dysentery, stop bleeding, promote wound repair, skin diseases, tambave, Urinary tract infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gaulettes Serr&#x000e9;es</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 October 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0009462</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.53</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dictyosperma album</italic> (Bory) H. Wendl. &#x00026; Drude ex Scheff var. <italic>conjugatum</italic> H. E. Moore &#x00026; Gu&#x000e9;ho</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arecaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palmiste blanc</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not described</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R&#x000e9;duit, Joseph Gu&#x000e9;ho Arboretum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 August 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0016674</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.52</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Erythroxylum sideroxyloides</italic> Lam</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Erythroxylaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bois de ronde</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal stones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower Gorges National Park, &#x02018;Morne Sec&#x02019;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 October 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0016542</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.81</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ficus mauritiana</italic> Lam</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moraceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Figuier du pays</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not described</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gaulettes Serr&#x000e9;es</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 November 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0011002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hancea integrifolia</italic> (Willd.) S.E.C. Sierra, Kulju and Welzen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Euphorbiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bois pigeon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clean the blood and improve blood circulation, tonic.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gaulettes Serr&#x000e9;es</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 November 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0016431</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.42</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Stillingia lineata</italic> Muell. Arg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Euphorbiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fangame; Bois de lait; Tanguin de pays</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eczema, skin disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower Gorges National Park, &#x02018;Morne Sec&#x02019;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 November 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0016545</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.28</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Terminalia bentzo&#x000eb;</italic> (L.) L.f. subsp. <italic>bentzo&#x000eb;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combretaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bois benjoin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma, antipyretic, antimalarial, chills, dysentery, diarrhoea, depurative, emmenagogue, haemorrhages, Sexually transmissible diseases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R&#x000e9;duit, Joseph Gu&#x000e9;ho Arboretum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 October 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAU 0016557</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.29</td></tr></tbody></table></table-wrap><table-wrap id="pharmaceuticals-13-00303-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t002_Table 2</object-id><label>Table 2</label><caption><p>Phenolic content and antioxidant potential of investigated leaf extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Phenolics <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Flavonoids <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Proanthocya Nidins <sup>3</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FRAP <sup>4</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Iron Chelating Activity <sup>5</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">DPPH Scavenging Activity <sup>6</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Superoxide Scavenging Activity <sup>6</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nitric Oxide Scavenging Activity <sup>6</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>A. borbonica</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">70.2 &#x000b1; 4.72 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.15 &#x000b1; 0.07 <sup>d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.71 &#x000b1; 0.09 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.32 &#x000b1; 0.16 <sup>d,e,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">4.05 &#x000b1; 0.26 <sup>b,c,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">11.2 &#x000b1; 1.63 <sup>d,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">19.0 &#x000b1; 2.46 <sup>d,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">80.3 &#x000b1; 29.0 <sup>b,</sup>**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>D. album</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">75.7 &#x000b1; 5.22 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.43 &#x000b1; 0.06 <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">30.9 &#x000b1; 0.58 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.21 &#x000b1; 0.05 <sup>e,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">4.83 &#x000b1; 1.49 <sup>c,d,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">7.89 &#x000b1; 0.13 <sup>c,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">32.7 &#x000b1; 1.16 <sup>f,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">68.0 &#x000b1; 10.0 <sup>a,</sup>*</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. sideroxyloides</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">182 &#x000b1; 10.5 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.62 &#x000b1; 0.13 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">121 &#x000b1; 3.25 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.14 &#x000b1; 0.85 <sup>b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">1.46 &#x000b1; 0.02 <sup>a,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">4.44 &#x000b1; 0.26 <sup>b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">12.7 &#x000b1; 0.65 <sup>c,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">24.3 &#x000b1; 1.39 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>F. mauritiana</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">133 &#x000b1; 2.36 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.4 &#x000b1; 0.21 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">85.7 &#x000b1; 2.38 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.38 &#x000b1; 0.01 <sup>c,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43 &#x000b1; 0.01 <sup>a,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">5.35 &#x000b1; 0.23 <sup>b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">24.2 &#x000b1; 0.44 <sup>e,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">87.08 &#x000b1; 28.9 <sup>b,</sup>***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>H. integrifolia</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">142 &#x000b1; 4.91 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.75 &#x000b1; 0.06 <sup>e,f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">18.4 &#x000b1; 0.78 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.37 &#x000b1; 0.29 <sup>b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">0.78 &#x000b1; 0.01 <sup>a,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">4.16 &#x000b1; 0.16 <sup>b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">9.55 &#x000b1; 0.78 <sup>b,</sup>***</td><td align="center" valign="middle" rowspan="1" colspan="1">68.49 &#x000b1; 37.5 <sup>a,b,</sup>**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>S. lineata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">97.7 &#x000b1; 3.36 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.61 &#x000b1; 0.19 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">4.53 &#x000b1; 0.02 <sup>c,d,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">6.45 &#x000b1; 0.02 <sup>d,</sup>*</td><td align="center" valign="middle" rowspan="1" colspan="1">4.04 &#x000b1; 0.17 <sup>a,b,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">3.81 &#x000b1; 0.48 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">68.5 &#x000b1; 42.9 <sup>b,</sup>**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>T. bentzo&#x000eb;</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">385 &#x000b1; 24.1 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.9 &#x000b1; 0.45 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">18.2 &#x000b1; 0.01 <sup>a,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10 &#x000b1; 0.00 <sup>a,</sup>****</td><td align="center" valign="middle" rowspan="1" colspan="1">2.65 &#x000b1; 0.14 <sup>a,</sup>***</td><td align="center" valign="middle" rowspan="1" colspan="1">5.20 &#x000b1; 0.53 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.74 &#x000b1; 3.13 <sup>a</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gallic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.8 &#x000b1; 0.22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.00 &#x000b1; 0.04<break/>(47.0 &#x000b1; 0.23 mM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.62 &#x000b1; 0.05<break/>(4.18 &#x000b1; 0.32 &#x000b5;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.52 &#x000b1; 0.11<break/>(31.4 &#x000b1; 0.84 &#x000b5;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.61 &#x000b1; 1.75<break/>(68.0 &#x000b1; 13.9 &#x000b5;M)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Values are expressed as mg of gallic acid equivalent (GAE)/g; <sup>2</sup> values are expressed as mg of quercetin equivalent (QE)/g; <sup>3</sup> values are expressed as mg of cyanidin chloride equivalent (CCE)/g; <sup>4</sup> values are expressed in mmol Fe<sup>2+</sup>; <sup>5</sup> IC<sub>50</sub> values are expressed in mg/mL; <sup>6</sup> IC<sub>50</sub> values are expressed in &#x000b5;g/mL; Data represent mean &#x000b1; standard error of mean (<italic>n</italic> = 3). ND = Not detected. Different letters between rows in each column represent significant differences between extracts (<italic>p</italic> &#x0003c; 0.05). Letter &#x0201c;a&#x0201d; represent the most potent/ highest abundance, while letter &#x0201c;f&#x0201d; least potent/lowest abundance in terms of antioxidant activity and polyphenolics content, respectively. Asterisks represent significant differences between extracts and gallic acid (positive control), * <italic>p</italic> &#x02264; 0.05, ** <italic>p</italic> &#x02264; 0.01, *** <italic>p</italic> &#x02264; 0.001, **** <italic>p</italic> &#x02264; 0.0001.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00303-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t003_Table 3</object-id><label>Table 3</label><caption><p>Cytotoxicity (IC<sub>50</sub> &#x000b5;g/mL) of <italic>T. bentzo&#x000eb;</italic> against human cancer cell lines.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SW872</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">A549</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HepG2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OVCAR-4</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OVCAR-8</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HOE</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>T. bentzo&#x000eb;</italic> extracts</td><td align="center" valign="middle" rowspan="1" colspan="1">45.4 &#x000b1; 1.8 ****</td><td align="center" valign="middle" rowspan="1" colspan="1">96.8 &#x000b1; 4.9 ****</td><td align="center" valign="middle" rowspan="1" colspan="1">22.8 &#x000b1; 1.3 ****</td><td align="center" valign="middle" rowspan="1" colspan="1">30.1 &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1">38.5 &#x000b1; 4.2</td><td align="center" valign="middle" rowspan="1" colspan="1">55.5 &#x000b1; 9.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etoposide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.8 &#x000b1; 0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.7 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 &#x000b1; 0.1</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean calculated IC<sub>50</sub> values with a standard error of the mean (<italic>n</italic> = 3). NA = Etoposide at 1 &#x000b5;g/mL. Inhibited above 80% cancer cell growth, indicating a much lower concentration is required for determination of IC<sub>50</sub> value. Asterisks represent significant differences between <italic>T. bentzo&#x000eb;</italic> and etoposide (positive control), **** <italic>p</italic> &#x02264; 0.0001.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00303-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t004_Table 4</object-id><label>Table 4</label><caption><p>Tail length, tail intensity and olive tail moment of H<sub>2</sub>O<sub>2</sub> and <italic>T. bentzo&#x000eb;</italic> treated HepG2 cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts and Controls</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tail Length (&#x000b5;m)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tail Intensity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Olive Tail Moment</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Negative control (Culture medium)</td><td align="center" valign="middle" rowspan="1" colspan="1">32.8 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#x000b1; 0.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>T. bentzo&#x000eb;</italic> extract 10 &#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">38.5 &#x000b1; 0.4 ****</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7 &#x000b1; 0.2 ****</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.0 ****</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive control (200 &#x000b5;M H<sub>2</sub>O<sub>2</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.8 &#x000b1; 7.2 ****</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.8 &#x000b1; 2.6 ****</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.1 &#x000b1; 0.6 ****</td></tr></tbody></table><table-wrap-foot><fn><p>Asterisks represent significant differences between plant extract and untreated control, **** <italic>p</italic> &#x02264; 0.0001.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00303-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t005_Table 5</object-id><label>Table 5</label><caption><p>Cytotoxic and antioxidant potential of <italic>T. bentzo&#x000eb;</italic> leaf fractions and the isolated punicalagin (1).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>T. bentzo&#x000eb;</italic> Fractions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> (&#x000b5;g/mL) Against HepG2 Cells</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FRAP <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">DPPH <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Superoxide Scavenging Activity <sup>2</sup></th></tr></thead><tbody><tr><td colspan="2" align="center" valign="middle" rowspan="1">Ethyl Acetate</td><td align="center" valign="middle" rowspan="1" colspan="1">20.8 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">21.98 &#x000b1; 0.29 <sup>a,b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.17 &#x000b1; 0.02 <sup>d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.43 &#x000b1; 0.14 <sup>b</sup></td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">Butanol</td><td align="center" valign="middle" rowspan="1" colspan="1">18.3 &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">21.01 &#x000b1; 0.56 <sup>b,c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.98 &#x000b1; 0.06 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.65 &#x000b1; 0.10 <sup>b</sup></td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Aqueous Residual</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.8 &#x000b1; 5.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.29 &#x000b1; 0.16 <sup>e</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78 &#x000b1; 0.07 <sup>b,c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.70 &#x000b1; 0.20 <sup>a,b</sup></td></tr><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>T.bnetzoe butanol</italic> Subfractions</td><td align="center" valign="middle" rowspan="1" colspan="1">F1</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">3.04 &#x000b1; 0.10 <sup>g</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F2</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">13.62 &#x000b1; 0.16 <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.65 &#x000b1; 0.04 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">16.90 &#x000b1; 0.35 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F3</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">13.80 &#x000b1; 0.14 <sup>e,f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.79 &#x000b1; 0.12 <sup>b,c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.80 &#x000b1; 0.28 <sup>a,b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F4</td><td align="center" valign="middle" rowspan="1" colspan="1">28.9 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">14.42 &#x000b1; 0.27 <sup>e,f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.09 &#x000b1; 0.08 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.96 &#x000b1; 0.12 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F5</td><td align="center" valign="middle" rowspan="1" colspan="1">25.7 &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1">18.46 &#x000b1; 0.15 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.71 &#x000b1; 0.07 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.71 &#x000b1; 0.10 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6</td><td align="center" valign="middle" rowspan="1" colspan="1">15.7 &#x000b1; 1.8</td><td align="center" valign="middle" rowspan="1" colspan="1">23.01 &#x000b1; 0.68 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.19 &#x000b1; 0.09 <sup>d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.03 &#x000b1; 0.20 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F7</td><td align="center" valign="middle" rowspan="1" colspan="1">19.9 &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1">20.94 &#x000b1; 0.49 <sup>b,c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.01 &#x000b1; 0.07 <sup>d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.15 &#x000b1; 0.18 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F8</td><td align="center" valign="middle" rowspan="1" colspan="1">24.6 &#x000b1; 5.9</td><td align="center" valign="middle" rowspan="1" colspan="1">19.86 &#x000b1; 0.29 <sup>c,d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.12 &#x000b1; 0.06 <sup>d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.76 &#x000b1; 0.08 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F9</td><td align="center" valign="middle" rowspan="1" colspan="1">22.3 &#x000b1; 3.1</td><td align="center" valign="middle" rowspan="1" colspan="1">18.82 &#x000b1; 0.3 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.99 &#x000b1; 0.06 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.33 &#x000b1; 0.24 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F10</td><td align="center" valign="middle" rowspan="1" colspan="1">26.7 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">18.47 &#x000b1; 0.28 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.34 &#x000b1; 0.04 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.05 &#x000b1; 0.23 <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09 &#x000b1; 0.02 <sup>h</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Active HPLC Subfractions</td><td align="center" valign="middle" rowspan="1" colspan="1">F6.1 (Punicalagin (<bold>1</bold>))</td><td align="center" valign="middle" rowspan="1" colspan="1">15.8 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6.3</td><td align="center" valign="middle" rowspan="1" colspan="1">27.5 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">17.4 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6.5</td><td align="center" valign="middle" rowspan="1" colspan="1">22.1 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6.6</td><td align="center" valign="middle" rowspan="1" colspan="1">19.6 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F6.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.6 &#x000b1; 0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Values are expressed in units of mmol Fe<sup>2+</sup>/gFDW; <sup>2</sup> Values are expressed in units of &#x000b5;g/mL; Data represent mean with a standard error of the mean (<italic>n</italic> = 3). Different letters between rows in each column represent significant differences between extracts (<italic>p</italic> &#x0003c; 0.05). Letter &#x0201c;a&#x0201d; represent the most potent antioxidant activity, while letter &#x0201c;g&#x0201d; represent the least potent activity. ND = IC<sub>50</sub> value not reached at maximum test dose. &#x0201c;-&#x0201c; = Not tested.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00303-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00303-t006_Table 6</object-id><label>Table 6</label><caption><p>Identification of phenolic compound in <italic>T. bentzo&#x000eb;</italic> butanol fraction F6 using high-resolution mass spectrometry, NMR spectroscopy, and comparison with the literature and available data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Number</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT/min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Negative ESI-MS [M &#x02212; H]<sup>&#x02212;</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecular Formula</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.76</td><td align="center" valign="middle" rowspan="1" colspan="1">1083.0555</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>48</sub>H<sub>28</sub>O<sub>30</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">Punicalagin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B24-pharmaceuticals-13-00303" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceuticals-13-00303" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceuticals-13-00303" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceuticals-13-00303" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.08</td><td align="center" valign="middle" rowspan="1" colspan="1">1083.0555</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>48</sub>H<sub>28</sub>O<sub>30</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">Isoterchebulin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B24-pharmaceuticals-13-00303" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.58</td><td align="center" valign="middle" rowspan="1" colspan="1">1085.0710</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>48</sub>H<sub>30</sub>O<sub>30</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">Terflavin A</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B28-pharmaceuticals-13-00303" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4.97</td><td align="center" valign="middle" rowspan="1" colspan="1">635.0867</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>24</sub>O<sub>18</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">3,4,6-trigalloyl-&#x003b2;-<sc>d</sc>-glucopyranose</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-pharmaceuticals-13-00303" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.25</td><td align="center" valign="middle" rowspan="1" colspan="1">599.1017</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>28</sub>H<sub>24</sub>O<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">2&#x0201d;-<italic>O</italic>-galloyl-orientin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B25-pharmaceuticals-13-00303" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.25</td><td align="center" valign="middle" rowspan="1" colspan="1">599.1017</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>28</sub>H<sub>24</sub>O<sub>15</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">2&#x0201d;-<italic>O</italic>-galloyl-isoorientin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B25-pharmaceuticals-13-00303" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>7</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.53</td><td align="center" valign="middle" rowspan="1" colspan="1">583.1074</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>28</sub>H<sub>24</sub>O<sub>14</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">2&#x0201d;-<italic>O</italic>-Galloylvitexin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B25-pharmaceuticals-13-00303" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceuticals-13-00303" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>8</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300.9987</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>14</sub>H<sub>6</sub>O<sub>8</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ellagic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-pharmaceuticals-13-00303" ref-type="bibr">24</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>